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ABSTRACT 
Guillain-Barré Syndrome (GBS) is a debilitating inflammatory autoimmune 
disease of the peripheral nervous system that is characterized by rapid-onset paraparesis 
with areflexia progressing, in some patients, to neuromuscular paralysis. GBS occurs 
with an incidence of 2-4 cases per 100,000, similar to that reported for multiple sclerosis. 
Recognized as a heterogeneous disorder, the most common (85-90%) form of GBS 
observed in North America and Europe is acute inflammatory demyelinating 
polyneuropathy (AIDP). Enhanced infiltration of pro-inflammatory type 1 helper T (Th1) 
cells into peripheral nerves of AIDP patients is strongly suggestive of an immune-
mediated pathogenic process. Cellular immunity directed against specific constituents of 
the peripheral nerve myelin is considered causal in AIDP, leading to segmental 
demyelination and secondary axonal loss. The treatment of AIDP is currently palliative 
and utilizes non-specific immune-modulating therapies.  
Increasing evidence now supports the application of exercise as a safe and 
effective non-pharmacological rehabilitative intervention strategy. Exercise attenuates the 
onset and progression of some autoimmune diseases and improves some measures of 
peripheral nerve function in diabetic neuropathy. In type 1 diabetes mellitus, exercise 
diminishes disease severity by promoting a type 2 helper T (Th2) protective immune 
response. In patients with GBS, exercise has been shown to increase muscle strength 
recovery and aerobic exercise capacity, decrease fatigue, and improve quality of life. 
 xvii 
Whether exercise alters the progression of GBS remains unclear. 
In this study, we determined the effects of forced-exercise on development and 
progression of experimental autoimmune neuritis (EAN), an established animal model of 
AIDP. We report that a moderate regimen of forced-exercise significantly attenuates the 
severity of actively induced EAN in Lewis rats. We also investigated the mechanism by 
which forced-exercise alters the development of EAN. Adult male Lewis rats were 
randomized to three groups: sedentary adjuvant control, sedentary EAN, and forced-
exercise EAN. Rats assigned to the forced-exercise group were trained on a motorized 
treadmill (6 km per week) for three weeks. Sedentary rats were allowed to explore the 
treadmill for the same duration of time without exercise. After three weeks, rats received 
a single injection of complete Freund’s adjuvant (CFA controls) or were actively 
immunized with an emulsified mixture of complete Freund’s adjuvant containing P2 
peptide fragment (53-78, EAN). CFA control-injected rats did not develop EAN. By 
comparison, sedentary rats immunized with CFA containing P2 peptide developed a 
monophasic course of EAN. In contrast, rats subjected to forced-exercise and injected 
with CFA containing P2 peptide exhibited a significantly attenuated course of EAN. In 
addition, during severe EAN, forced-exercise rats lost less weight than sedentary rats. 
This attenuation was most likely not due to stress hormone levels since levels were 
similar in sedentary and forced-exercise EAN rats. Near peak of disease, evoked 
compound muscle action potential amplitudes were significantly reduced in sedentary 
rats compared to forced-exercise rats with mild EAN. In contrast, forced-exercise did not 
protect against deficits in evoked compound muscle action potential amplitudes, or 
conduction velocities, and in sciatic nerve pathology in sedentary and forced-exercise rats 
 xviii 
with severe EAN. Lymphocytes recovered from the popliteal lymph nodes of forced-
exercise EAN rats exhibited increased proliferative response to P2 peptide compared to 
sedentary EAN controls. Moreover, the supernatant obtained from the lymphocyte 
proliferation assays of forced-exercise EAN rats near onset and peak of disease show a 
marked increase in the anti-inflammatory cytokine interleukin-10. When analyzed by 
flow cytometry, the percentage of Th1 lymphocytes present in lymph nodes, spleen, and 
blood of forced-exercise EAN rats were reduced compared with sedentary EAN controls. 
Collectively, these data support a protective effect of forced-exercise against the 
development of EAN, in part, by selectively enhancing anti-inflammatory cytokine 
release and decreasing percent distribution of pro-inflammatory autoreactive Th1 
lymphocytes.
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CHAPTER I 
INTRODUCTION 
 
Statement of the Problem 
Human peripheral neuropathies affect approximately 2.4% of the population, 
causing a burden on the healthcare system (White et al., 2004). Peripheral neuropathies 
are a disparate group of diseases that are heterogeneous in etiology, diverse in pathology, 
and varied in severity (Martyn and Hughes, 1997). Current interventions for treating 
peripheral neuropathies are largely limited to management of discomfort and pain 
(Martyn and Hughes, 1997; White et al., 2004). 
Guillain-Barré Syndrome (GBS) is an acute acquired autoimmune mediated 
human peripheral neuropathy with an incidence of about four cases per 100,000 people. 
Males are more commonly affected than females (Alter, 1990; Hughes and Rees, 1997; 
Cosi and Versino, 2006; Vucic et al., 2009). GBS encompasses a spectrum of clinical 
disorders characterized by acute and sub-acute progressive weakness of at least two 
limbs, usually beginning in the legs, for up to four weeks (Asbury et al., 1978; Hughes 
and Rees, 1997; Vucic et al., 2009). GBS affects motor and sensory nerves of the arms 
and legs and may involve the respiratory muscles and the facial, bulbar, and ocular motor 
nerves (Hughes and Rees, 1997). Autonomic nerve involvement can occur causing urine 
retention, ileus, sinus tachycardia hypertension, cardiac arrhythmia, and postural 
hypotension. Respiratory failure occurs in 25% of patients with GBS, with general 
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supportive therapy needed (Hughes and Cornblath, 2005; Vucic et al., 2009). 
In North America and Europe, GBS typically presents in the form of acute 
inflammatory demyelinating polyneuropathy (AIDP) (Hadden et al., 1998; Hughes and 
Cornblath, 2005; Vucic et al., 2009). This common variant of GBS involves multifocal 
mononuclear cell infiltration of the peripheral nervous system (Asbury et al., 1969; 
Hughes and Cornblath, 2005; Vucic et al., 2009). Autoreactive pro-inflammatory 
lymphocytes and macrophages invade the myelin, thus demyelinating and damaging the 
axon, leading to paraparesis, paralysis, and areflexia of the limbs. Similar disease 
pathology has been shown to occur in experimental autoimmune neuritis (EAN), an 
established animal model of GBS (Hughes and Cornblath, 2005; Vucic et al., 2009). 
The treatment of AIDP/GBS is currently palliative and utilizes non-specific 
immune-modulating therapies. Plasmapheresis or intravenous immunoglobulin therapies 
currently benefit the GBS patient by reducing the need for supportive care and expediting 
recovery. However, these benefits are generally observed only if treatment is 
administered early in the course of the disease (Hughes and Cornblath, 2005; Vucic et al., 
2009). While most patients recover from GBS, there is a mortality rate of about 10% in 
population-based studies, and at least 10% of survivors are left with severe disability 
(Hughes and Rees, 1997; Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome 
Trial Group, 1997; Vucic et al., 2009). Advancement of care for these affected patients 
waits on the development of new selective immune-modulating agents or the novel 
application of existing therapeutic strategies.  
Increasing evidence now supports the application of exercise as a safe and 
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effective non-pharmacological rehabilitative intervention. Exercise decreases 
inflammatory diseases by increasing anti-inflammatory and decreasing pro-inflammatory 
cytokines, and by reducing pro-inflammatory toll-like receptor signaling on innate 
immune cells (Gleeson et al., 2006; Gleeson, 2007; Rosa Neto et al., 2010). Exercise 
attenuates the onset and progression of autoimmune diseases and peripheral neuropathies 
(Le Page et al., 1994; Le Page et al., 1996; White et al., 2004; Lowder et al., 2010; 
Navarro et al., 2010). In multiple sclerosis, exercise improves the quality of life, in part, 
by attenuating pro-inflammatory cytokine production (Schulz et al., 2004; White et al., 
2006a; White et al., 2006b). Exercise also decreases peripheral neuropathy in type 2 
diabetes mellitus by decreasing pro-inflammatory cytokines and leukocyte-endothelial 
interactions and adhesion (Fisher et al., 2003; Balducci et al., 2006; Gleeson et al., 2006; 
Roberts et al., 2006; Fisher et al., 2007; Hopps et al., 2011; Teixeira-Lemos et al., 2011a). 
In patients with GBS, exercise has been shown to increase muscle strength recovery and 
aerobic exercise capacity, decrease fatigue, and improve the quality of life (Garssen et al., 
2004; El Mhandi et al., 2007). However, the effects of exercise on immune parameters of 
GBS were not studied. In this dissertation research study, we determined the mechanism 
by which exercise attenuates the onset and progression of experimental autoimmune 
neuritis. 
Hypothesis 
Forced-exercise protects against the onset and progression of experimental 
autoimmune neuritis, in part, by suppressing pro-inflammatory type 1 helper T (Th1) cell-
mediated autoimmunity. 
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Specific Aims 
The hypothesis was tested with the following two specific aims. 
 
Specific Aim 1 
We determined whether forced-exercise protects against the onset and progression 
of EAN in adult male Lewis rats. This was accomplished with the following sub-aims: 
 1A. Effects of forced-exercise on the clinical onset and progression of EAN, compared 
with sedentary controls, were quantified using established blinded scoring criteria. 
 1B. Effects of forced-exercise on EAN-induced changes in peripheral nerve function, 
compared with sedentary controls, were quantified by evoked-response 
electrophysiology. 
 1C. Effects of forced-exercise on EAN-induced changes in peripheral nerve pathology, 
compared with sedentary controls, were semi-quantified by light microscopy. 
Specific Aim 2 
We determined whether forced-exercise protects against the onset and progression 
of EAN in adult male Lewis rats by a mechanism that alters pro-inflammatory Th1 and 
anti-inflammatory type 2 helper T (Th2) cell activation. This was accomplished with the 
following sub-aims: 
 2A. Effects of forced-exercise on EAN-induced changes in P2 peptide or lectin-
stimulated nodal and splenic lymphocyte proliferation, compared with sedentary 
controls, were quantified by [
3
H]thymidine uptake. 
 2B. Effects of forced-exercise on EAN-induced changes of Th1 and Th2 cell 
populations in the spleen, popliteal lymph nodes, or blood, compared with 
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sedentary controls, were quantified by flow cytometric analyses. 
 2C. Effects of forced-exercise on EAN-induced changes in P2 peptide or lectin-
stimulated nodal and splenic lymphocyte cytokine production, compared with 
sedentary controls, were quantified by multiplex immunoassay. 
 2D. Effects of forced-exercise on corticosterone and corticosteroid-binding globulin, 
compared with sedentary controls, were quantified by enzyme-linked 
immunosorbent assay and radioimmunoassay, respectively. 
A major finding of this dissertation is that a pre-induction three-week regimen of 
moderate forced-exercise attenuates the clinical severity, weight loss, and peripheral 
nerve damage of P2 peptide induced EAN in Lewis rats, an animal model of GBS. Our 
results show that in forced-exercise EAN rats, there is increase retention of adaptive 
immune cells in the popliteal lymph nodes and spleens. Lymphocytes obtained from 
popliteal lymph nodes of forced-exercise EAN rats have increased capacity to proliferate 
near peak of disease when stimulated with P2 peptide. Moreover, the supernatant 
obtained from the lymphocyte proliferation assays of forced-exercise EAN rats show a 
marked increase in the anti-inflammatory cytokine interleukin-10. Lymphocytes obtained 
from spleens of forced-exercise EAN rats have an increased capacity to proliferate when 
stimulated with ConA. Flow cytometric analysis of adaptive immune cells obtained from 
popliteal lymph nodes, spleens, and blood of forced-exercise EAN rats show a clear 
decrease in pro-inflammatory Th1 cells. These results illustrate that forced-exercise has 
anti-inflammatory effects that can attenuate EAN in rats. To our knowledge, this is the 
first study to show attenuation of the clinical severity of EAN by moderate intensity 
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forced-exercise. 
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CHAPTER II 
LITERATURE REVIEW 
Human Peripheral Neuropathies 
Peripheral neuropathies affect approximately 2.4% of the population, causing a 
burden on the national healthcare systems (Martyn and Hughes, 1997; White et al., 
2004). Peripheral neuropathies are a heterogeneous group of genetic or acquired disorders 
where one or all parts of the peripheral nervous system are damaged. Patients with 
peripheral neuropathies develop symptoms of numbness or altered sensation, usually 
starting at the extremities and progressing proximally, and muscle weakness (White et al., 
2004). Peripheral neuropathies are disabling, and improved interventions to alleviate the 
symptoms of peripheral neuropathies are critically needed.  
Autoimmunity 
Autoimmune diseases are a family of more than 80 chronic, and often debilitating, 
diseases affecting more than 14.7 million people in the United States (The Autoimmune 
Diseases Coordinating Committee, 2005). The prevalence of these diseases is rising. A 
better understanding of autoimmunity is crucial for future treatments. 
In a normal immune response, a foreign antigen is recognized and endocytosed by 
antigen presenting cells (APCs). These foreign antigens are recognized by toll-like
receptors (TLRs) expressed on APCs, which are pattern recognition receptors that 
recognize pathogenic antigens (Toubi and Shoenfeld, 2004; Waldner, 2009; Torres-
8 
 
 
Aguilar et al., 2010). APCs, such as dendritic cells, macrophages, and B cells, migrate to 
secondary lymphoid organs where these APCs present the foreign antigen in the context 
of major histocompatibility complex class II (MHC II) and co-stimulatory signals, CD80 
and CD86, to naïve T cells with specific T cell receptors to that foreign antigen 
(Romagnani, 2006; Mackay, 2008). These T cells clonally expand. After clonal 
expansion, naïve T cells differentiate into a specific subset of helper T cells that 
participate in cell-mediated or humoral-mediated immune responses (Zhu and Paul, 2008; 
Veldhoen, 2009). The differentiated helper T cells then egress from the lymph nodes into 
circulation to survey and attack the foreign antigen (Mackay, 2008). Eventually, these 
activated and differentiated immune cells will encounter the foreign antigen at the 
affected target organ and will initiate a cascade of events, including release of cytokines 
and activation of macrophages and B cells to dispose of the foreign antigen (Romagnani, 
2006; Mackay, 2008; Veldhoen, 2009; Torres-Aguilar et al., 2010). When this process 
involves a self-antigen, then the immune response is targeted at self-tissue and/or organs. 
This is defined as autoimmunity (Toubi and Shoenfeld, 2004; Romagnani, 2006; Mackay, 
2008; Veldhoen, 2009; Waldner, 2009; Torres-Aguilar et al., 2010). 
 The immune system has in place a set of checkpoints to prevent the 
development of an immune response against a self-antigen (Goodnow et al., 2005; Parish 
and Heath, 2008). In the first checkpoint against autoimmunity, thymic T cells undergo 
central tolerance, a process of selecting T cells that strongly recognize self-antigen. 
Thymic T cells that strongly recognize self-antigen either undergo further rearrangement 
of antigen-receptor genes to avoid reactivity to self-antigen or face deletion by apoptosis 
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(Fathman and Lineberry, 2007; von Boehmer and Melchers, 2010). However, central 
tolerance is only 60 to 70 percent efficient, with many of the autoreactive T cells 
escaping to the secondary lymphoid organs (Parish and Heath, 2008). 
Autoreactive T cells that escape central tolerance are naïve (ignorant) but can be 
activated by APCs that have processed and presented a self-antigen to the T cells in the 
context of MHC II (Parish and Heath, 2008). In the second checkpoint against 
autoimmunity, autoreactive T cells can undergo peripheral tolerance, involving anergy, 
deletion by apoptosis, or suppression when presented with a self-antigen by an APC 
(Goodnow et al., 2005; Romagnani, 2006; Parish and Heath, 2008). Through anergy, 
APCs present to the T cells the self-antigen in the context of MHC II without the 
necessary co-stimulatory receptors CD80 and CD86, thus making the T cells functionally 
inactive to future interactions with an APCs (Romagnani, 2006). Deletion through 
apoptosis (activation-induced cell death) occurs when T cells encounter high antigen 
concentrations or when T cells are heavily activated, and is mediated by high expression 
of Fas and its ligand Fas ligand (Romagnani, 2006). Finally, peripheral tolerance can 
occur through suppression. Autoreactive T cells can be suppressed by type 1 regulatory T 
cells (Tr1), a subset of helper T cells known to control immune response to antigens by 
secreting the anti-inflammatory cytokine IL-10 (Romagnani, 2006). 
Peripheral tolerance can be overcome by bystander activation or molecular 
mimicry (Romagnani, 2006). In bystander activation, pathogenic microbes induce 
inflammation and release of sequestered self-antigens from apoptotic cells. These self-
antigens are then processed by APCs and presented to autoreactive T cells causing 
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autoimmunity (Romagnani, 2006). In molecular mimicry, foreign antigens from 
pathogenic microbes can strongly resemble self-antigens. When APCs process and 
present these foreign antigens to autoreactive T cells, the resulting immune response will 
not be able to distinguish between the foreign and self-antigens, and self-tissues and/or 
organs will be compromised (Rose and Mackay, 2000; Romagnani, 2006; Ryan et al., 
2007). Both bystander activation and molecular mimicry are dependent on the self-
antigens being recognized by TLRs on the APCs. The levels of TLRs on APCs differ 
depending on the inflammatory milieu encountered by APCs. For example, inflammation 
caused by an infection of pathogenic microbes can increase surface expression of TLRs 
causing robust processing of the self-antigen by the APCs (Toubi and Shoenfeld, 2004; 
Waldner, 2009; Torres-Aguilar et al., 2010). 
 The final checkpoint to autoimmunity is whether activated T cells to self-
antigens differentiate into helper T cells that participate in pro-inflammatory cell-
mediated or anti-inflammatory humoral-mediated immunity (Figure 1). The pro-
inflammatory cell-mediated immunity is represented by type 1 helper T (Th1) and T 
helper 17 (Th17) cells, and is responsible for the pathogenesis of autoimmune 
disorders(Zhu and Paul, 2008). The up regulation of T-bet transcription factor 
differentiates naïve T cells to become a Th1 cells, which are characterized by secretion of 
pro-inflammatory cytokine interferon-γ (IFN-γ), and the proliferative cytokine 
interleukin-2 (IL-2) (Zhu and Paul, 2008). The up regulation of ROR-γ transcription 
factor differentiates naïve T cells to become Th17 cells, which are characterized by 
secretion of pro-inflammatory cytokine interleukin-17 (IL-17) and the cytokine 
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Figure 1. Naïve T cell fates. Adapted from (La Cava, 2008; Zhu and Paul, 2008). 
IFN-γ, IL-2 IL-4, IL-10 
IL-17, IL-6 TGF-β, IL-10 
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interleukin-6 (IL-6) (Zhu and Paul, 2008). The anti-inflammatory arm of cellular 
immunity is represented by type 2 helper T (Th2) and regulatory T (Treg) cells, and is 
responsible for allergic diseases (La Cava, 2008; Zhu and Paul, 2008; Veldhoen, 2009; 
Steward-Tharp et al., 2010). The up regulation of GATA-3 transcription factor 
differentiates naïve T cells to become Th2 cells, which is characterized by secretion of 
anti-inflammatory cytokines interleukin-4 (IL-4) and IL-10 (Zhu and Paul, 2008). The up 
regulation of Foxp3 transcription factor differentiates naïve T cells to become Treg cells, 
which are characterized by secretion of anti-inflammatory cytokine IL-10 and the 
cytokine transforming growth factor-β (TGF-β) (Zhu and Paul, 2008). 
Differentiation of pro-inflammatory or anti-inflammatory autoreactive T cells 
during self-antigen presentation by APCs is determined by the activation status of APCs 
and cytokine milieu. For example, immature and mature dendritic cells can present the 
self-antigen to autoreactive naïve T cells. However, the immature and semi-mature 
dendritic cells express low levels of MHC II and the co-stimulatory molecules CD80 and 
CD86 and secrete less pro-inflammatory cytokines. This leads to decreases in 
differentiation of pro-inflammatory T cells, or increases in differentiation of autoreactive 
naïve T cells into Tregs that suppress pro-inflammatory cell-mediated immune responses. 
In contrast, mature dendritic cells expressing high levels of MHC II and the co-
stimulatory molecules CD80 and CD86 differentiate autoreactive naïve T cells into Th1 
and Th17 cells (Fehervari and Sakaguchi, 2004; Toubi and Shoenfeld, 2004; Romagnani, 
2008; Torres-Aguilar et al., 2010). Moreover, the cytokine milieu derived from dendritic 
cells, macrophages, and contracting muscles (Nielsen and Pedersen, 2008), can 
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differentiate autoreactive naïve T cells into specific subsets (La Cava, 2008; Zhu and 
Paul, 2008; Torres-Aguilar et al., 2010). For example, during APC presentation of self-
antigen, IFN-γ, interleukin-12 (IL-12), and interleukin-18 (IL-18) can differentiate 
autoreactive naïve T cells into Th1 cells, while IL-4 and IL-2 can differentiate 
autoreactive naïve T cells into Th2 cells. Moreover, TGF-β and IL-2 can differentiate 
autoreactive naïve T cells into Treg cells, while TGF-β, IL-6, interleukin-21, and 
interleukin-23 differentiate autoreactive naïve T cells into Th17 cells (Zhu and Paul, 
2008). 
Guillain-Barré Syndrome 
The autoimmune disease Guillain-Barré Syndrome (GBS) encompasses a 
heterogeneous set of clinical syndromes in which idiopathic autoimmune peripheral 
neuropathy causes acute or sub-acute weakness of at least two limbs, usually starting in 
the legs, which progresses for up to four weeks and then reaches plateau (Hughes and 
Rees, 1997; Hughes and Cornblath, 2005; Vucic et al., 2009). GBS symptoms also 
include: parasthesia/dysaesthesia, backache/root pain, meningism, and muscle, joint, or 
visceral pain, though most cases of pain recover spontaneously at varying intervals after 
the onset of disease (Pentland and Donald, 1994). GBS can be divided into several 
patterns of pathology (Figure 2) (Ho et al., 1998). 
Two patterns of mainly axonal involvement can be categorized in GBS: acute 
motor axonal neuropathy (AMAN) and acute motor sensory axonal neuropathy 
(AMSAN). AMAN is due to axonal degeneration without a prior demyelination of the 
peripheral motor nerves (Ho et al., 1998; Hughes and Cornblath, 2005; Vucic et al., 
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2009). Generally, AMAN is characterized by weakness or paralysis without sensory loss. 
AMAN is diagnosed when electrophysiological studies of patients with GBS show a 
reduction in compound muscle action potential (CMAP) amplitudes without prominent 
conduction slowing. AMAN most commonly occurs in children in Asian countries, with 
antecedent Campylobacter jejuni infection, which suggests molecular mimicry (Ho et al., 
1998; Kuwabara, 2004; Hughes and Cornblath, 2005; Kuwabara, 2007; Vucic et al., 
2009). In fact, antigens on the C. jejuni are similar to those located at the nodes of 
Ranvier, signifying that AMAN is most likely a humoral-mediated immune response 
against the axon. Autoantibodies to gangliosides, such as GM1, GM1b, or GD1a, bind at 
the nodes of Ranvier leading to complement-mediated destruction and macrophage 
invasion, resulting in Wallerian-like degeneration (Li et al., 1996; Ho et al., 1998; 
Hughes and Cornblath, 2005; Vucic et al., 2009). 
AMSAN is similar to AMAN in that it involves Wallerian-like degeneration 
and/or conduction block of peripheral motor nerves. Where AMSAN differs is that 
peripheral sensory nerves also undergo Wallerian-like degeneration and/or conduction 
block (Ho et al., 1998; Kuwabara, 2004, 2007). The incidence of AMSAN is very low, 
being less than 10 percent of AMAN (Kuwabara, 2004, 2007; Vucic et al., 2009). 
Another variant of GBS is Miller-Fisher Syndrome (MFS), which is characterized 
by acute onset of unstable gait (ataxia), loss of reflexes (areflexia), and inability to move 
the eyes (ophthalmoplegia). Autoantibodies to the gangliosides GQ1b and GT1a are 
heavily distributed on oculomotor nerves and to a lesser extent on motor nerve terminals 
of somatic musculature, sensory neurons in the dorsal root ganglion, and a population of   
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Figure 2. An operational classification of GBS and related syndromes. Adapted from 
(Ho et al., 1998). 
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cerebellar neurons. Some cases of MFS are preceded by an antecedent infection of C. 
jejuni, which bear epitopes similar to GQ1b and GT1a, thus implicating molecular 
mimicry (Ho et al., 1998; Kuwabara, 2004; Hughes and Cornblath, 2005; Kuwabara, 
2007; Vucic et al., 2009).  
When GBS was first described, it was previously characterized only by 
lymphocytic infiltration/inflammation and peripheral nervous system (PNS) 
demyelination. With the realization that GBS encompasses many subtypes, the GBS form 
of lymphocytic infiltration/inflammation and PNS demyelination is now clinically 
defined as acute inflammatory demyelinating polyneuropathy (AIDP) (Ho et al., 1998). 
AIDP is the most common form of GBS in developed countries and is responsible for 85-
90% of the patients with GBS (Kuwabara, 2004, 2007; Vucic et al., 2009). 
AIDP is characterized by demyelination, and pro-inflammatory lymphocyte and 
macrophage infiltration. In some cases of AIDP, axonal degeneration may follow 
demyelination. Clinically, patients present with flaccid paralysis, areflexia, and some 
sensory loss (Hughes and Cornblath, 2005; Kuwabara, 2007; Vucic et al., 2009). 
Electrophysiological studies of the peripheral nerves usually reveal increases in distal 
latencies and absence of F waves or increases in F wave latencies, and reductions in 
nerve conduction velocities and CMAP amplitudes (Hughes and Cornblath, 2005; Vucic 
et al., 2009; Uncini et al., 2010). Also, early in AIDP, there are decreased proximal-to-
distal CMAP amplitude ratios that, later in the disease, return to normal (Uncini et al., 
2010). This signifies length-dependent CMAP amplitude reduction, and is thought to be 
due to demyelinating lesions scattered along the nerve followed by axonal degeneration 
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(van der Meche et al., 1988; Uncini et al., 2010). Many markers of pro-inflammatory T 
cell activation, including soluble IL-2 receptor, IL-12, IL-18, and tumor necrosis factor-α 
(TNF-α), are found in the serum of AIDP patients (Ho et al., 1998; Lu and Zhu, 2010). 
Moreover, GBS patients have decreased percentages of anti-inflammatory regulatory T 
cells that may cause a dysregulation of pro-inflammatory Th1 cells (Pritchard et al., 2007; 
Vucic et al., 2009). An alternative, but not mutually exclusive, hypothesis is that the 
binding of autoantibodies to the Schwann cell is followed by complement-mediated 
destruction of peripheral myelin (antibody-dependent cell-mediated cytotoxicity) 
(Hughes and Cornblath, 2005; Vucic et al., 2009). Evidence for this theory comes from 
low incidence of antecedent infection of C. jejuni. It is thought that unknown antibodies 
against C. jejuni cross-reacts with self-antigens expressed on Schwann cells, thus 
implicating molecular mimicry (Ho et al., 1998; Hughes and Cornblath, 2005; Kuwabara, 
2007; Vucic et al., 2009). 
Treatment for Guillain-Barré Syndrome 
A multidisciplinary approach is needed to prevent and manage potentially fatal 
complications of GBS. Respiratory failure occurs in about 25% of patients and early 
transfer to an intensive care unit for pre-induction intubation is required. Patients are also 
monitored for cardiac arrhythmia, autonomic failure, and vein thrombosis. Other 
complications requiring medical care are pain, urinary retention, and ileus (Hughes and 
Cornblath, 2005; Kuwabara, 2007; Vucic et al., 2009). 
Immunotherapy is used as a treatment for GBS. These non-specific immune-
modulating therapies are indicated for patients who are unable to walk, and they consist 
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of plasmapheresis (PES) or intravenous immunoglobulin (IVIg) infusion (Ho et al., 
1998). Both treatments help to speed the recovery of the patient, but only if the 
treatments are implemented early (before 4 weeks for PES and before 2 weeks for IVIg) 
in the disease (Hughes and Cornblath, 2005; Vucic et al., 2009). IVIg and PES have 
similar outcomes and either should be offered to patients who are considered immobile 
(Cortese et al., 2011).The mechanism of IVIg therapy remains to be understood, but it is 
thought that IVIg modulates complement activation products, neutralizes idiotypic 
antibodies, saturates the Fc receptors on macrophages, and suppresses various pro-
inflammatory mediators, such as cytokines, chemokines, and matrix metalloproteinases 
(Kuwabara, 2004, 2007). The combination of PES and IVIg does not add an extra benefit 
to the recovery of GBS (Hughes et al., 2007; Kaida and Kusunoki, 2009; Vucic et al., 
2009). 
Corticosteroids are widely used as a therapy in autoimmune disorders. However, 
in studies with GBS patients, corticosteroids failed to modulate the course of the disease 
(Kuwabara, 2004; Kaida and Kusunoki, 2009; Vucic et al., 2009). One possible 
explanation for the lack of benefit seen in corticosteroid treatment is that corticosteroids 
might adversely affect the recovery process by inhibiting macrophage clearance of 
myelin debris and hinder remyelination of the peripheral nerves (Hughes and Cornblath, 
2005; Kaida and Kusunoki, 2009). 
Even though current therapies help to speed the recovery process, there is a 
pressing need to find more effective and specific immune modulating therapies for the 
treatment of GBS and related neuropathies. 
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Experimental Autoimmune Neuritis 
Experimental autoimmune Neuritis (EAN) is an animal model that closely 
resembles AIDP. It is induced by immunization with peripheral nerve myelin or its 
proteins, P2, P0, or PMP22 (Hughes and Cornblath, 2005; Kaida and Kusunoki, 2009). It 
is also induced by adoptive transfer of autoreactive T cells reactive towards P2, P0, or 
PMP22 protein (Gold et al., 2000; Hughes and Cornblath, 2005). The main mechanism of 
EAN is a pro-inflammatory autoreactive Th1 cell-mediated response against one or more 
of the myelin proteins (Figure 3). Due to activation of the adaptive immune response by 
innate immune cells, the activated pro-inflammatory autoreactive Th1 cells , as part of 
normal immune surveillance, egress from secondary lymphoid organs into the circulation, 
cross the blood-nerve barrier (BNB), encountering a cross-reactive antigen in the 
endoneurium (Spies et al., 1995a; Maurer and Gold, 2002; Hughes and Cornblath, 2005; 
Schwab and Cyster, 2007). The activated autoreactive Th1 cells release pro-inflammatory 
cytokines, which break down the BNB, and recruit and stimulate macrophages and 
autoreactive cytotoxic T cells. Macrophages are the effector cells invading the myelin 
sheaths and causing demyelination (Maurer and Gold, 2002; Hughes and Cornblath, 
2005; Lu and Zhu, 2010). Autoreactive cytotoxic T cells play a role in EAN by migrating 
to peripheral nerves and releasing the cytotoxins perforin, granzymes, and granulysin 
(Constantinescu et al., 1998; Pelidou et al., 2000; Yun et al., 2007). In addition, 
autoantibodies against the myelin proteins produced by autoreactive T cell-activated B 
cells can enter the compromised BNB and cause conduction block of the peripheral 
nerves. The autoantibodies can also activate complement-mediated destruction of 
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peripheral nerve myelin (Hughes et al., 1981; Spies et al., 1995b; Maurer and Gold, 2002; 
Vucic et al., 2009). 
EAN, similar to AIDP, is a monophasic disease (Gold et al., 2000). It is induced 
in Lewis rats. Starting as early as ten days after active immunization with purified P2 
peptide fragment, animals begin to lose muscle tone in the tail. Progression of EAN is 
characterized by weakness (paraparesis) or paralysis in the hind limbs. In severe cases, 
paraparesis or paralysis of the fore limbs and respiratory muscles can occur, leading to 
death. Weight loss is common, and begins before the clinical symptoms of EAN appear. 
Tactile sensitivity testing of the hind paws reveals tactile hypersensitivity before onset of 
clinical symptoms (Moalem-Taylor et al., 2007; Luongo et al., 2008; Zhang et al., 
2008b). Electrophysiological studies show a reduction in motor nerve conduction 
velocity, and CMAP amplitudes at peak EAN severity compared to pre-immunization 
responses. The neuropathological features of EAN include demyelination of the 
peripheral nerves and nerve roots, infiltration of lymphocytes and macrophages, and 
nerve edema. In severe EAN, axonal damage may follow demyelination (Harvey and 
Pollard, 1992; Sarkey et al., 2007). Many of the immunopathological mechanisms of EAN 
are well understood, making it important tool for the development of specific therapies in 
autoimmune disease. 
Exercise, Autoimmunity and Guillain-Barré Syndrome 
Exercise has potent anti-inflammatory effects on the innate and adaptive immune 
systems (Figure 4).Regarding innate immunity, exercise is known to alter innate  
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Figure 3. Pathogenesis of AIDP/EAN. m, macrophage; T (blue), autoreactive naïve T 
cell; T (red), autoreactive activated T cell; B, autoreactive activated B cell; C5-9, 
complement activation by autoantibody; NO, nitric oxide. Adapted from (Hughes and 
Cornblath, 2005; La Cava, 2008). 
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immune cell trafficking (Woods et al., 1999; Sugiura et al., 2000; Ho et al., 2001; Chiang 
et al., 2010; Suchanek et al., 2010), decrease TLRs, and alter APC function (Woods et al., 
1999; Lancaster et al., 2005; Flynn and McFarlin, 2006; Gleeson et al., 2006; McFarlin et 
al., 2006; Lambert et al., 2008; Timmerman et al., 2008; Simpson et al., 2009; Oliveira 
and Gleeson, 2010). 
Regarding adaptive immunity, exercise is known to increase (Sugiura et al., 2000; 
Rogers et al., 2008), or decrease (Moraska et al., 2000; Nielsen, 2003; Gleeson et al., 
2006; Gleeson, 2007; Rosa Neto et al., 2010) lymphocyte proliferation, increase 
differentiation of anti-inflammatory T cells and secretion of anti-inflammatory cytokines 
while decreasing pro-inflammatory T cells and cytokines (Lancaster et al., 2004; Pastva 
et al., 2004; Yeh et al., 2006; Flynn et al., 2007; Gleeson, 2007; da Silva Krause and de 
Bittencourt, 2008; Donnikov et al., 2008; Haaland et al., 2008; Nielsen and Pedersen, 
2008; Yeh et al., 2008; Hewitt et al., 2009b; Lowder et al., 2010; Rosa Neto et al., 2010), 
and impair the T cell-mediated induction phase of an in vivo immune response (Harper 
Smith et al., 2011). Moreover, exercise can increase catecholamines and glucocorticoids 
(Woods et al., 1999; Pastva et al., 2005; Ortega et al., 2007; Hewitt et al., 2009a) 
decreasing a pro-inflammatory immune response. Exercise can also alter immune cell 
trafficking by promoting lymphocyte egress into peripheral tissues (Chen et al., 2010; 
Turner et al., 2010; Adams et al., 2011). With many pleiotropic anti-inflammatory effects 
on the innate and adaptive immune systems, exercise can be a safe and effective non-
pharmacological rehabilitative intervention for inflammatory diseases. 
Exercise reduces the complications associated with type 2 diabetes. Exercise 
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increases the release of anti-inflammatory cytokines from muscles, and decreases the 
release of pro-inflammatory cytokines from adipose tissue (Nielsen and Pedersen, 2008; 
Hopps et al., 2011), thus decreasing inflammation. Diabetic men who exercised had 
significant reductions in pro-inflammatory cytokines, leukocyte-endothelial interactions 
and adhesion, and peripheral neuropathy (Fisher et al., 2003; Balducci et al., 2006; 
Roberts et al., 2006; Fisher et al., 2007). Similarly, in a rat model of type 2 diabetes 
mellitus, exercise was shown to decrease pro-inflammatory cytokines (Teixeira de Lemos 
et al., 2009; Teixeira-Lemos et al., 2011a). 
Exercise is known to affect autoimmune and inflammatory diseases in humans. In 
asthma, an inflammatory disease of the airways, exercise decreases disease-related 
hospital admission of asthmatics (Lucas and Platts-Mills, 2005). In patients with 
rheumatoid arthritis (RA), an inflammatory cell-mediated autoimmune disease with signs 
and symptoms of joint and systemic inflammation, exercise increases strength and quality 
of life, and decreases pain, fatigue, and inflammation (Metsios et al., 2010; Hurley et al., 
2011). In patients with multiple sclerosis (MS), an inflammatory cell-mediated 
autoimmune demyelinating disease of the central nervous system, exercise increases 
fitness parameters and quality of life, and decreases fatigue and pro-inflammatory 
cytokines (TNF-α, IFN-γ,) (Schulz et al., 2004; White et al., 2006a; White et al., 2006b; 
Castellano et al., 2008). Patients suffering from GBS also benefit from exercise. For these 
patients, exercise improves physical fitness and muscle strength and decreases recovery 
time, fatigue, anxiety, and depression (Garssen et al., 2004; El Mhandi et al., 2007). 
However, the effects of exercise on immune parameters have not been investigated   
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Diagram 3. Possible mechanisms by which exercise increases susce ptibility to infection 
but reduces inflammation and risk of developing chronic disease. TLR, Toll-like 
receptor; TH1, T helper 1; IL -1ra, IL-1 receptor antagonist. The encircled minus sign 
represents an inhibitory action of IL -6 on TNF production. Adopted from 49.
 
 
 
  
Figu  4. Exercise reduces inflammation a d risk of chronic disease. TLR, toll-like 
receptor; TH1, typ  1 helper T cell; IL-1ra, interleukin-1 rec pto  antagonist; IL-10, 
int rl ukin-10. Adap ed from (Gleeson, 2007). 
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in GBS patients. 
In the mouse model of MS, experimental autoimmune encephalomyelitis (EAE), 
forced-exercise has been shown to decrease the clinical severity and delay the onset of 
symptoms (Le Page et al., 1994; Le Page et al., 1996; Rossi et al., 2009). Three weeks of 
exercise in rats has been shown to increase blood-brain barrier function by decreasing 
expression of matrix metalloproteinases (Guo et al., 2008). In studies of EAE, the blood-
brain barrier becomes permeable to lymphocytes (Engelhardt, 2006), and thus exercise 
might have a therapeutic role in MS. In an animal model of RA, collagen-induced 
arthritis (CIA), exercise has been shown to decrease severity of CIA by decreasing 
immune cell activation and increasing blood glucocorticoids (Navarro et al., 2010). In the 
mouse model of asthma, ovalbumin-induced asthma, exercise has been shown to decrease 
severity of asthma by increasing glucocorticoids, and increasing the percentage and 
suppressive activity of anti-inflammatory Tregs with a concomitant increase in anti-
inflammatory cytokines, while decreasing pro-inflammatory cytokines and transcription 
factors (Pastva et al., 2004; Pastva et al., 2005; Hewitt et al., 2009b; Lowder et al., 2010). 
There have been no studies on the effects of exercise on EAN. However, due the 
anti-inflammatory effects of exercise, EAN might be attenuated. Moreover, further 
beneficial effects of exercise in the PNS are increased capacity of axonal regeneration 
and sprouting after peripheral nerve injury and decreased age-related apoptosis of 
Schwann cells (Ilha et al., 2008; Sabatier et al., 2008; Shokouhi et al., 2008). Promoting 
regeneration or decreasing Schwann cell apoptosis in EAN or GBS would be ideal as a 
therapeutic intervention. To our knowledge, the effect of exercise on EAN has not been 
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investigated, and the beneficial effects of exercise may attenuate this autoimmune 
peripheral neuropathy.
 27 
CHAPTER III 
MATERIAL AND METHODS 
This study was conducted using protocols approved by the Edward Hines Jr. VA 
Institutional Animal Care and Use Committee in accordance with the principles of 
laboratory animal care (Institute for Laboratory Animal Research, 2010). Male Lewis rats 
(6-8 weeks of age; 200-220g) were housed two to a cage and allowed free access to 
Harlan 2018 rat chow and water ad libitum. Rats were maintained on a 12h/12h light/dark 
cycle. Tissue harvest and blood collection were performed between the hours of 0500 and 
0800. For induction of experimental autoimmune neuritis (EAN) and for 
electrophysiological studies, rats were anesthetized with a combination of ketamine (90 
mg/kg) and xylazine (7.5 mg/kg). 0.1 M phosphate-buffered saline (PBS) (pH 7.4) was 
used in this study. 
Forced-Exercise Experimental Design 
Rats were randomized to two groups: sedentary control or forced-exercise. Rats 
randomized to the forced-exercise group were acclimated to treadmill running using an 
Exer-3R motorized treadmill apparatus equipped with a motivational electric shock grid 
set at 20 µA (Columbus Instruments, USA). During acclimation, rats were subjected to 
treadmill training at 15 m/min x 20 minutes on the first day. Subsequently, rats were
 subjected to progressively faster and longer training sessions until the fifth day of 
training where the rats ran consistently at 20 m/min x 60 minutes. Rats acclimated to 
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treadmill training received an additional three weeks of forced-exercise at 20 m/min x 60 
minutes, five days a week. Sedentary control rats were allowed to explore a similar 
“treadmill” environment for an identical duration of time but without receiving exercise. 
Both sedentary and forced-exercise rats were weighed daily throughout this study. 
Induction of Mild Experimental Autoimmune Neuritis 
At the completion of the three-week sedentary- or forced-exercise program, all 
rats were actively induced with experimental autoimmune neuritis (EAN), an established 
animal model of acquired inflammatory demyelinating neuropathy (AIDP), the 
predominant subtype of Guillain-Barré Syndrome (GBS) occurring in North America and 
Europe. EAN was induced (day 0) by injecting in the base of the tail (Figure 5) 100 μl of 
an emulsified 1:1 PBS:CFA (Sigma, USA) solution containing a final concentration of 5 
mg/ml heat-inactivated H37RA Mycobacteria tuberculosis (Difco, USA) and 100 µg of 
commercially prepared P2 peptide (residues 53-78 of bovine P2 myelin protein; Dana-
Farber Cancer Institute, Harvard University, USA). Forced-exercise rats immunized at 
the base of the tail were allowed to continue their training throughout the disease course. 
All rats were closely observed for development of EAN. Clinical assessment of 
EAN severity was performed by investigators blinded to group assignment and was semi-
quantified as follows: 0 = normal; 1 = limp tail; 2 = abnormal gait; 3 = mild paraparesis; 
4 = severe paraparesis; 5 = hind limb paraplegia. Intermediate scores were assigned using 
0.5 increments. Rats were sacrificed near peak (day 18) of EAN. 
Induction of Severe Experimental Autoimmune Neuritis 
At the completion of the three-week sedentary- or forced-exercise program, all 
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rats were actively induced with EAN, an aggressive animal model of AIDP. EAN was 
induced (day 0) by injecting in the hind left footpad (Figure 6) 100 μl of an emulsified 
1:1 PBS:CFA (Sigma, USA) solution containing a final concentration of 5 mg/ml heat-
inactivated H37RA Mycobacteria tuberculosis (Difco, USA) and 100 µg of commercially 
prepared P2 peptide (residues 53-78 of bovine P2 myelin protein; Dana-Farber Cancer 
Institute, Harvard University, USA). Forced-exercised rats immunized in the hind left 
footpad were not subsequently subjected to further training due to the local inflammatory 
response. 
As an immunization antigen-free adjuvant (CFA) control, a subgroup of sedentary 
rats were injected in the hind left footpad with 100 μl of an emulsified 1:1 PBS:CFA 
solution containing 5 mg/ml of heat-inactivated H37RA Mycobacteria Tuberculosis in 
the absence of added antigen.  
All rats were weighed daily and closely observed for development of EAN. 
Clinical assessment of EAN severity was performed by investigators blinded to group 
assignment and was semi-quantified as follows: 0 = normal; 1 = limp tail; 2 = abnormal 
gait; 3 = mild paraparesis; 4 = severe paraparesis; 5 = hind limb paraplegia. Intermediate 
scores were assigned using 0.5 increments. Rats were further subdivided into two disease 
groups, sacrificed either near onset (day 14) or near peak (day 18) of EAN. 
Peripheral Nerve Conduction Studies 
Evoked-response electrophysiological studies (Figure 7) were performed on rats 
prior to induction of (day 0) and near peak (day 18) of mild (Figure 5) and severe EAN 
(Figure 6). Evoked compound muscle action potential (CMAP) amplitudes and latencies 
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were recorded from the right leg of ketamine/xylazine sedated rats as previously 
described (Sarkey et al., 2007). Briefly, evoked responses were elicited from the ankle 
(tibial nerve, distal) or the sciatic notch (sciatic nerve, proximal) with unipolar needle 
electrodes using supramaximal stimuli (25 mA, 0.05 ms duration). Evoked compound 
muscle action potential (CMAP) amplitudes were recorded from the plantar muscles with 
needle electrodes. Body temperature of the sedated rat was maintained near 37° C with an 
activated thermal heating pad. A series of 25 individual responses were evoked at a 
frequency of 1 Hz. Evoked responses were amplified, recorded, and averaged using a 
Teca Synergy electromyograph system (CareFusion, USA). Each response series was 
repeated three times. Proximal/distal ratios (R ratios) were calculated using the following 
formula: proximal CMAP amplitude ∕ distal CMAP amplitude. Motor nerve conduction 
velocities (MNCVs) were calculated using the following formula: distance between ankle 
and sciatic notch placed electrodes (typically 55 mm) ∕ (sciatic notch latency recording – 
ankle latency recording). 
Neuropathology 
Near peak of severe EAN (day 18) (Figure 6), rats were sacrificed by CO2 
asphyxiation, and sciatic nerves were rapidly harvested and immediately post-fixed in 
ice-cold 2% paraformaldehyde (Sigma, USA) + 2.5% glutaraldehyde (EMS, USA) PBS  
(pH 7.4) solution for 48 hours at 4° C. Fixed nerves were washed in PBS, osmicated by 
brief immersion in 1% OsO4, dehydrated by washing with ascending series of alcohol 
solutions (50-100%) and propylene oxide. Dehydrated nerves were embedded in Embed-
812 (Electron Microscopy Sciences, USA). Serial transverse sections (0.5 μm thick) were 
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cut using a Reichert Ultracut S microtome and stained with 0.5% toluidine blue/borax 
solution. Stained sections were examined by light microscopy using a Leitz DMRB 
inverted phase-contrast microscope equipped with a Leica Wild MPS photographic 
system (W. Nuhsbaum, USA). Histopathological changes (inflammatory infiltrates, 
myelin ovoids, or damaged axons) in sciatic nerves were quantified by two investigators 
blinded to group assignment by using a four-point scoring system as follows: 0 = normal; 
1 = mild demyelination, axonal damage, or cellular infiltrates; 2 = moderate 
demyelination, axonal damage, or cellular infiltrates; 3 = severe demyelination, axonal 
damage, or cellular infiltrates (Sarkey et al., 2007). 
Proliferation Assay 
Rats were sacrificed by CO2 asphyxiation near onset (day 14) or near peak (day 
18) of severe EAN, and spleens and popliteal lymph nodes were harvested (Figure 6). 
Splenic lymphocytes were cleared of contaminating red blood cells by brief exposure to 
ammonium chloride lysing buffer (155 mM NH4Cl, 10 mM KHCO3, 0.1 mM Na2EDTA; 
pH 7.4). Lymphocytes were prepared as a single-cell suspension. Prepared splenic or 
nodal lymphocytes were cultured at an initial density of 2.0 x 10
6
 cells/ml in RPMI-1640 
GlutaMAX-I media supplemented with 9% heat-inactivated fetal bovine serum 
(Invitrogen, USA), 0.05 μM 2-mercaptoethenol, 90 U/ml penicillin and 90 μg/ml 
streptomycin.  
Cells were assayed for 96 hours in either the absence (antigen-free control) or 
presence of 10 µg/ml of P2 peptide or 5 µg/ml of the lectin concanavalin A (Sigma, 
USA). To determine proliferation indices, 0.5 µCi of [
3
H]thymidine (6.7 Ci/mmol; MP
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Figure 7. Representative M wave tracings from the rat left plantar muscle 
stimulated at the ankle or sciatic notch. A recording electrode was placed in the plantar 
muscle of the rat, and M waves were recorded by stimulating distally at the ankle or 
proximally at the sciatic notch as described in Materials and Methods (top). Adapted 
from (Lawlor et al., 2001). Representative tracing from one rat are shown (bottom). 
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Biomedicals, USA) was added to each culture for the final 24 hours of control-, antigen-, 
or lectin-stimulation. Cells were briefly trypsinized and collected by centrifugation. DNA 
was precipitated with ice-cold 10% (w/v) trichloroacetic acid, solubilized with NaOH, 
neutralized with HCl, and an aliquot was added to 5 ml of Beckman Coulter Ready Safe 
liquid scintillation counting cocktail. Disintegrations per minute (dpm) of [
3
H]thymidine 
incorporated into the splenic or nodal lymphocyte DNA was quantified using a Tri-Carb 
2810 liquid scintillation analyzer (Perkin Elmer, USA). Stimulation indices were 
calculated as a ratio of dpm of DNA recovered in antigen- or lectin-stimulated cultures to 
dpm of DNA recovered in un-stimulated cultures (Sarkey et al., 2007). 
Cytokines 
Splenic or nodal leukocytes harvested near onset (day 14) or near peak (day 18) of 
severe EAN (Figure 6) were cultured for 96 hours at a density of 2.0 × 10
6
 cells/ml in the 
absence or presence of 10 µg/ml of P2 peptide or 5 µg/ml of concanavalin A. Cell culture 
supernatants were collected and analyzed for the presence of interleukin-2, interleukin-4 
interleukin-6, interleukin-10, interleukin-12p70, interferon-γ, and tumor necrosis factor-α 
pro- or anti-inflammatory cytokines. The content of cytokines present in culture 
supernatant were quantified simultaneously using multiplex technology with an available 
Bio-plex system (Bio-Rad Laboratories, USA) and a commercially available rat-specific 
cytokine Milliplex kit (Millipore, USA). 
Flow Cytometric Analysis 
Splenic, nodal, or blood lymphocytes were prepared from rats sacrificed near 
onset (day 14) or near peak (day 18) of severe EAN (Figure 6). Blood was collected in 5 
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mM EDTA tubes. 
To determine the relative abundance of CD4
+
 and CD8
+
 T cells, splenic, nodal, or 
blood lymphocyte preparations were co-incubated at a density of 1 x 10
6
 cells for 30 min 
at 4° C in the presence of 1 µg each of FITC-conjugated mouse anti-rat CD4 (clone 
W3/25), and PE-conjugated mouse anti-rat CD8α (clone G28) monoclonal antibodies 
(BioLegend, USA).  
To determine the relative abundance of type 1 helper T (Th1, CD4
+
) cells 
(Yamane et al., 2000; Ozenci et al., 2001; McQuaid et al., 2003; Kano et al., 2008) or 
activated cytotoxic T (Tc, CD8
+
) cells (McQuaid et al., 2003; Bontkes et al., 2005), 
splenic, nodal, or blood lymphocyte preparations were co-incubated at a density of 1 x 
10
6
 cells for 30 min at 4° C in the presence of 1 µg of rabbit anti-rat IL-12Rβ1 (clone C-
20) monoclonal antibody (Santa Cruz Biotechnology) followed by incubation in the 
presence of 1 µg APC-conjugated F(ab')2 fragment goat anti-rabbit IgG (H+L) (Jackson 
ImmunoResearch, USA) as a secondary antibody. 
To determine the relative abundance of type 2 helper T (Th2, CD4
+
) cells (Rojo et 
al., 2008; Zhu and Paul, 2008; Simpson et al., 2010), prepared splenic, nodal, and blood 
lymphocyte preparations were co-incubated at a density of 1 x 10
6
 cells for 30 min at 4° 
C in the presence of 1 µg of FITC-conjugated mouse anti-rat CD4 (clone W3/25) and PE-
conjugated hamster anti-rat CD278 (clone C398.4A) monoclonal antibodies (BioLegend, 
USA). 
Co-immunostained cells from splenic or nodal lymphocyte preparations were 
washed twice with ice-cold serum (5% bovine calf serum)-supplemented PBS. Washed 
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cells were re-suspended in 1 ml of ice-cold 4% p-formaldehyde PBS (pH 7.4). After 10 
min, fixed cells were washed twice and re-suspended in serum-supplemented PBS. 
Co-immunostained cells from blood were incubated with CAL-LYSE red blood 
cell lysing solution (Invitrogen, USA) according to manufacturer’s protocol. After 
incubation, cells were washed twice and re-suspended in serum-supplemented PBS.  
Cytometric data were collected using an available FACS Canto flow cytometer 
(BD Biosciences, USA) and analyzed with FlowJo software (Tree Star, Inc., USA). 
Lymphocytes were gated according to their forward and side scatter. In all cases, isotype 
controls were used to quantify and correct for background fluorescence. 
A summary of differentiated T cells and their corresponding cell surface markers 
used in flow cytometric analyses are summarized in Table 1. 
Corticosterone and Corticosteroid-Binding Globulin 
To determine changes in corticosteroid levels in response to forced-exercise, 
blood was collected from sedentary control or forced-exercise rats gently sacrificed (CO2 
asphyxiation) near onset (day 14) or near peak (day 18) of severe EAN (Figure 6), 
plasma prepared and stored at -80º C until use. Rats were sacrificed in the morning 
between 0500 and 0800 hours. Plasma corticosterone levels were quantified using a 
commercially available competitive radioimmunoassay kit (Siemens Healthcare 
Diagnostics, USA). 
Corticosteroid-binding globulin (CBG) levels in plasma were similarly quantified 
by competitive radioimmunoassay according to (Westphal, 1971; Brown et al., 2007). 
Briefly, plasma (20 µl) was pre-clarified with a dextran-coated charcoal (DCC) solution  
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Table 1. Summary of differentiated T cells and their corresponding cell 
surface markers used for flow cytometric analyses. 
Differentiated T cells 
Cluster of 
Differentiation (CD) 
Other Names 
Naïve helper T (Th) cell CD4 - 
Type 1 helper T (Th1) 
cell 
CD4 - 
CD212 
Interelukin-12 receptor β1 
(IL-12Rβ1) 
Type 2 helper T (Th2) 
cell 
CD4 - 
CD278 
Inducible T cell co-stimulator 
(ICOS) 
Cytotoxic T (Tc) cell CD8α - 
Activated cytotoxic T 
(activated Tc) cell 
CD8α - 
CD212 
Interelukin-12 receptor β1 
(IL-12Rβ1) 
Lymph node and spleen cells were prepared as described in Materials and Methods, and 
gated for lymphocytes according to forward and side scatter. 
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containing 0.5% activated charcoal (Sigma USA) and 0.05% dextran from Leuconostoc 
mesenteroides (Sigma, USA), centrifuged at 3000 g x 15 min, and the resultant clarified 
supernatant was diluted 1:2 (v/v) with 10 mM Tris buffer (pH 8.0) containing 1.0 mM 
EDTA, 10% glycerol (v/v), and 1.0 mM dithiothreitol. Clarified samples were aliquoted 
(100 µl) to four tubes, each containing 45 nM of [
3
H]corticosterone (70-78 Ci/mmol) 
(Perkin Elmer, USA). Unlabeled corticosterone (10 µM, Sigma, USA) was added to two 
tubes for determining non-specific binding. All tubes were incubated for 24 hours at 4°C. 
Ice-cold DCC (pH 7.4) was added to each tube and incubated for 10 min at 4°C. Samples 
were centrifuged at 3,000g at 4°C for 5 minutes to sediment DCC. An aliquot of the 
centrifuged sample was added to 5 ml of liquid scintillation Beckman Coulter Ready Safe 
counting cocktail. Disintegrations per minute of [
3
H]corticosterone were quantified using 
a Tri-Carb 2810 liquid scintillation analyzer (Perkin Elmer, USA). In all cases, non-
specific binding was subtracted from the total binding to calculate specific CBG content. 
Statistical Analyses 
Sedentary and forced-exercise EAN data are expressed as mean ± SEM and 
sedentary adjuvant control data are expressed as mean, of (n) observations unless 
otherwise specified. Statistical significance between parametric multiple groups (between 
sedentary and forced-exercise EAN groups, and between post-induction day 14 and 18) 
was determined using two-way ANOVA (group × time) followed by a post hoc all 
pairwise multiple comparison Holm-Sidak test. This statistical post-hoc test was chosen 
because it is more powerful than the Bonferroni post hoc test and has stricter control of 
the familywise error rate than Tukey post hoc test (Salkind and Rasmussen, 2007). When 
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appropriate, two-way repeated-measures ANOVA (group × time) followed by a post hoc 
all pairwise multiple comparison Holm-Sidak test was used. Non-parametric clinical and 
neuropathological data were statistically analyzed using a Mann-Whitney non-parametric U 
test analysis and one-way ANOVA on ranks followed by a post hoc all pairwise multiple 
comparisons Dunn’s test, respectively. Sedentary adjuvant controls were not included in 
statistical analyses, but were included in figures as a reference for non-disease values. In all 
cases, p < 0.05 was considered significant.
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CHAPTER IV 
RESULTS 
Forced-Exercise Attenuates Mild Experimental Autoimmune Neuritis 
Increasing evidence supports the novel use of exercise as a safe adjunctive 
strategy for the management of some nervous system disorders, including immune-
mediated peripheral neuropathies (Fisher et al., 2003; Garssen et al., 2004; Schulz et al., 
2004; Balducci et al., 2006; Roberts et al., 2006; White et al., 2006a; White et al., 2006b; 
El Mhandi et al., 2007; Fisher et al., 2007; Castellano et al., 2008). First we sought to 
determine whether forced-exercise protects against autoimmune neuropathy by treadmill 
exercising adult male Lewis rats three weeks before and during the onset and progression 
of actively induced mild (base of the tail injection) experimental autoimmune neuritis 
(EAN) (Figure 5), an established animal model of Guillain-Barré syndrome (Hughes and 
Cornblath, 2005).  
Prior to induction of mild EAN, Lewis rats were randomized to sedentary or 
forced-exercise training groups. Rats randomized to the forced-exercise group were 
subjected to daily 60 min sessions of running at a constant rate using a motorized 
treadmill as described within Methods and Materials. By comparison, rats randomized to 
the sedentary control group were allowed to explore a similar environment daily for 60
minutes without forced-exercise. 
Following sedentary or forced-exercise training, rats were induced with mild 
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EAN by injecting into the base of the tail an emulsified solution containing 100 µg of a 
neuritogenic peptide fragment of bovine peripheral nerve P2 protein (residues 53-78) as 
described within Methods and Materials (Figure 5). Immunization at the base of the tail 
was chosen as an optimal injection site given the design of subjecting animals to forced-
treadmill running. Within two-weeks of immunization, rats developed a monophasic 
course of paraparesis consistent with mild EAN (Figure 8; Table 1). Sedentary control 
rats immunized by injection at the base of the tail (Figure 8) developed clinical signs of 
mild EAN (defined here as a clinical score ≥ 0.5), beginning on post-induction day 12.33 
± 0.59 (n = 18; clinical score 0.61 ± 0.13) reaching peak severity at post-induction day 
15.83 ± 0.35 (n = 18; clinical score 2.42 ± 0.33). By comparison, rats undergoing forced-
exercise exhibited an attenuated monophasic course of mild EAN beginning on post-
induction day 12.63 ± 0.53 (n = 16; clinical score 0.61 ± 0.17, n = 18) reaching peak 
severity on post-induction day 14.69 ± 0.73 (n = 16; clinical score 1.33 ± 0.27, n = 18). 
At post-induction days 13 to 18, forced-exercise EAN rats exhibited significantly lower 
(improved) clinical scores when compared to sedentary control EAN rats (Figure 8). The 
onset of mild EAN in sedentary rats, however, did not differ significantly from that of 
forced-exercise rats (p = 0.60) (Table 1). Whereas the clinical severity of mild EAN was 
significantly attenuated in rats undergoing forced-exercise, the day at which mild EAN 
peaked in these animals did not differ significantly (p = 0.25) compared with sedentary 
control EAN rats (Table 1). Two rats from the forced-exercise group failed to develop 
clinical signs of mild EAN. 
Collectively, these data suggest that forced-exercise attenuates the development of  
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Figure 8. Forced-exercise attenuates mild EAN. Sedentary (open circles) or forced-
exercise (closed circles) trained rats were immunized with P2 peptide fragment by 
injection in the base of the tail at day 0 and were clinically evaluated for signs of mild 
EAN. Data shown are the means + SEM (n = 5-18). *p<0.05 vs. sedentary, Mann-
Whitney non-parametric U-test. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Effect of forced-exercise on development and clinical severity of 
mild EAN induced by injection in the base of the tail. 
 Mild EAN 
 
Sedentary 
(n = 18) 
Forced-exercise 
(n = 16-18) 
Clinical onset 
(post-induction day) 
12.33 (12) ± 0.59 12.63 (12) ± 0.53 
Clinical peak 
(post-induction day) 
15.83 (16) ± 0.35 14.69 (16) ± 0.73 
Peak clinical score 2.42 (2) ± 0.33 1.33 (1) ± 0.27* 
Data shown are the means (median) + SEM. Clinical onset is defined as the first day a 
minimum clinical score of 0.5 was reached. Clinical peak is defined as the first day a 
peak clinical score was reached. *p<0.05 vs. sedentary, Mann-Whitney non-parametric 
U-test. EAN, experimental autoimmune neuritis. 
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mild EAN. The mechanism by which this occurs was next addressed. 
 
Effect of Forced-Exercise on Mild EAN-Induced Peripheral Nerve Injury 
Previous studies demonstrate measurable deficits in peripheral nerve function 
following induction of severe EAN, supportive of an autoimmune-mediated 
inflammatory demyelinating nerve injury (Gabriel et al., 1997; Taylor and Pollard, 2001, 
2003; Lin et al., 2007; Sarkey et al., 2007). Whereas forced-exercise attenuates the 
clinical severity of mild EAN (Figure 8), we next determined whether the moderate 
training program used in this study would alter mild EAN-induced changes in peripheral 
nerve large-fiber function in Lewis rats. The effect of forced-exercise on peripheral nerve 
function was determined by evoked-response electrophysiology as described within 
Methods and Materials (Figure 5). 
As shown in Figure 8, rats immunized by injection in the base of the tail 
developed a mild course of EAN. Subjecting these animals to forced-exercise afforded a 
measure of protection against EAN-induced peripheral nerve injury (Figure 9). At post-
induction day 18, sedentary control rats with mild EAN exhibited a significant reduction 
in both ankle- (4.65 ± 0.52 mV, n = 18) [F1, 34 = 5.68, p = 0.02] and sciatic notch- (2.90 ± 
0.39 mV, n = 18) [F1, 34 = 4.41, p = 0.04] evoked compound muscle action potential 
(CMAP) amplitudes compared with pre-induction (day 0) responses (ankle 7.75 ± 0.46 
mV, n = 18; sciatic notch 5.48 ± 0.49 mV, n = 18). In marked contrast, rats with mild 
EAN undergoing forced-exercise exhibited preserved ankle- (6.27 ± 0.57 mV, n = 18) 
and sciatic-notch- (4.26 ± 0.42 mV, n = 18) evoked CMAP amplitude responses that were 
statistically indistinguishable compared with their respective pre-induction (day 0) 
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Figure 9. Effect of forced-exercise on evoked peripheral nerve conduction 
amplitudes in rats with mild EAN. Relative changes in peripheral nerve CMAP 
amplitudes were determined by evoke-response electrophysiology prior to and 18 days 
following immunization with P2 peptide fragment by injection into the base of the tail as 
described within Methods and Materials. Data shown are the means + SEM (n = 18) of 
rats undergoing sedentary (white bars) or forced-exercise (black bars) training. 
#
p<0.05 
vs. respective day 0 responses, *p<0.05 vs. respective day 18 sedentary control responses 
demonstrating protection; two-way repeated measures ANOVA with post hoc Holm-
Sidak multiple comparison test. 
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Figure 10. Effect of forced-exercise on R ratios in rats with mild EAN. Relative 
changes in peripheral nerve conduction ankle and notch amplitudes were determined by 
evoke-response electrophysiology, and R ratios calculated, prior to and 18 days following 
immunization with P2 peptide fragment by injection into the base of the tail as described 
within Methods and Materials. Data shown are the means + SEM (n = 18) of rats 
undergoing sedentary (white bars) or forced-exercise (black bars) training. These data 
were analyzed by two-way repeated measures ANOVA with post hoc Holm-Sidak 
multiple comparison test and were found to be statistically indistinguishable. 
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Figure 11. Effect of forced-exercise on mild EAN-induced slowing of peripheral 
nerve conduction velocity. Peripheral nerve conduction velocities were calculated from 
the experimental data shown in Fig. 6. Data shown are the means + SEM (n = 18) of rats 
undergoing sedentary (white bars) or forced-exercise (black bars) training. 
#
p<0.05 vs. 
respective day 0 responses; two-way repeated measures ANOVA with post hoc Holm-
Sidak multiple comparison test.  
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responses (Figure 9). Absolute values of sciatic-notch evoked CMAP amplitudes were 
approximately 20% lower in magnitude compared with ankle-evoked responses in 
sedentary control and forced-exercise groups; there were no differences in R ratios 
between the groups [F1, 34 = 0.23, p = 0.63] or between the post-induction days [F1, 34 = 
1.29, p = 0.26] (Figure 10). This could occur because of temporal dispersion or uniform 
demyelination (van der Meche et al., 1988; Harvey and Pollard, 1992; Lin et al., 2007; 
Daube and Rubin, 2009; Uncini et al., 2010). 
Base-of-the-tail injected rats undergoing sedentary (60.15 ± 3.55 m/s, n = 18) or 
forced-exercise (59.59 ± 3.08 m/s, n = 18) training exhibited nearly identical rates [F1, 34 
= 2.74, p = 0.11] of motor nerve conduction velocities (MNCVs) prior to immunization 
(Figure 11, day 0). By comparison, sedentary rats with mild EAN exhibited significant 
slowing of MNCV (47.79 ± 1.60 m/s, n = 18) by post-induction day 18. Whereas forced-
exercise rats with mild EAN also experienced significant slowing of MNCV (50.75 ± 
2.29 m/s, n = 18), this occurred to a lesser degree compared with sedentary controls [F1, 34 
= 23.5, p < 0.001] (Figure 11).  
Collectively, these data suggest that forced-exercise training program used in this 
study significantly attenuates the development of clinically mild EAN and its associated 
peripheral nerve electrophysiological deficits. 
Pre-Induction Forced-Exercise Attenuates Severe Experimental Autoimmune 
Neuritis 
 
We showed that forced-exercise before and during development and progression 
of mild EAN can attenuate the clinical and electrophysiological deficits of the disease. 
Next, we investigated whether three weeks of pre-induction exercise, in which Lewis rats 
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Figure 12. Effect of forced-exercise on weight gain in adult male Lewis rats. Rats 
undergoing forced-exercise on a motorized treadmill (solid circles) gained weight at a 
rate that was significantly less than sedentary controls (open circles). Data shown are the 
means + SEM (n = 27). *p<0.05 vs. sedentary control; two-way repeated measures 
ANOVA with post hoc Holm-Sidak multiple comparison test. 
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ceased running after induction, would similarly attenuate severe EAN induced by footpad 
P2 peptide injection. To determine the mechanism by which pre-induction exercise 
protects against autoimmune neuropathy, we challenged adult male Lewis rats to a 
moderate regimen of forced-exercise before induction and quantified clinically and 
immunologically the onset and progression of actively induced severe (hind left footpad 
injection) EAN (Figure 6). 
Prior to induction of EAN, male Lewis rats were randomized to sedentary or 
forced-exercise training groups. Rats randomized to the forced-exercise group were 
subjected to daily 60 min sessions of running at a constant rate using a motorized 
treadmill as described within Methods and Materials (Figure 6). By comparison, rats 
randomized to the sedentary control group were allowed to explore a similar environment 
daily for 60 minutes without forced-exercise. As shown in Figure 12, both groups of rats 
steadily gained body weight throughout the three-week sedentary or forced-exercise 
training. During this period, sedentary control rats gained body weight at a rate of 2.7 ± 
0.1 (n = 27) grams per day, consistent with previously published findings for male Lewis 
rats fed chow ad libitum (2.7 g/day, Harlan Lewis growth curve). In contrast, forced-
exercise rats exhibited a significantly reduced rate (1.8 ± 0.1 g/day, n = 27) of body 
weight gain [F19, 988 = 43.11, p < 0.001] (Figure 12). Post-hoc statistical analysis of these 
data revealed a significant difference in body weight gain between sedentary and forced-
exercise rats between days 15 to 26. These findings suggest that the forced-exercise 
regimen used in this dissertation was of a moderate level of intensity. Importantly, at no 
time throughout this study did rats randomized to the forced-exercise group exhibit a 
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frank loss of body weight. While food consumption between sedentary and forced-
exercise groups was not monitored in this study, rats undergoing forced-exercise gained 
body weight. These findings further suggest that secondary complications of confounding 
cachexia in response to forced-exercise were minimized. 
To determine whether forced-exercise was effective at protecting against a 
clinically severe form of EAN, rats were immunized by injection in the hind left footpad 
as previously described (Sarkey et al., 2007). Injection into the footpad necessitated a 
change in experiment design of particular noteworthy significance. Given the injection 
site, rats undergoing forced-exercise were unable to sustain physical activity following 
footpad immunization. Thus, the experimental distinction between sedentary and forced-
exercise footpad immunized rats was restricted to physical activity performed prior (pre-
induction) to induction of EAN.  
As previously reported (Sarkey et al., 2007), footpad-immunized sedentary 
control rats developed severe EAN (Figure 13; Table 2), beginning on post-induction 
day 12.33 ± 0.20 (n = 24; clinical score 0.75 ± 0.14) reaching peak severity at post-
induction day 17.00 ± 0.33 (n = 12; clinical score 3.99 ± 0.20). Despite cessation of 
training prior to EAN induction, rats undergoing pre-induction forced-exercise similarly 
exhibited an attenuated course of severe EAN beginning on post-induction day 12.64 
±0.22 (n = 21; clinical score 0.54 ± 0.12, n = 23) reaching peak severity on post-induction 
day 15.70 ± 0.15 (n = 10; clinical score 2.74 ± 0.32, n=12 ). At post-induction days 13 to 
18, rats undergoing pre-induction forced-exercise prior to EAN induction exhibited 
significantly lower clinical scores when compared to sedentary control EAN rats (Figure 
52 
 
 
13), suggesting a sustained effect of protection elicited by forced-exercise. The onset of 
EAN between sedentary and forced-exercise footpad immunized rats did not differ 
significantly (p = 0.53) (Table 2). A modest but significant difference in the day at which 
EAN peaked was observed between sedentary control and forced-exercise rats (Table 2). 
This difference was most likely due to lessening of disease development and severity by 
pre-induction forced-exercise. Two rats from the forced-exercise group failed to develop 
EAN.  
Another reliable and reproducible clinical sign of EAN developmental onset and 
progression is body weight loss (Figure 14). A significant difference in the percentage of 
body weight between rats injected with complete Freund’s adjuvant (CFA) in the absence 
of P2 peptide (adjuvant immunization control) compared with sedentary control and 
forced-exercised rats receiving CFA + P2 peptide was observed [F8, 264 = 4.67, p < 
0.001]. Post hoc statistical analyses revealed that at post-induction days 13 through 18, 
there was a significant attenuation of the percent body weight loss in CFA + P2 peptide 
injected forced-exercise rats compared with sedentary controls (Figure 14), consistent 
with exercise-facilitated clinical protection (Figure 13). 
Collectively, these data suggest that (i) pre-induction forced-exercise attenuates 
the development of severe EAN and (ii) the protective effect of pre-induction forced- 
exercise appears sustainable for several weeks after cessation of treadmill running. The 
mechanism by which this occurs was next addressed. 
Effect of Pre-Induction Forced-Exercise and Severe EAN on Steady State Content 
of Corticosterone 
 
One mechanism by which pre-induction forced-exercise may attenuate 
53 
 
 
8 9 10 11 12 13 14 15 16 17 18
0
1
2
3
4
Sedentary
Forced-Exercise
* *
*
*
*
CFA Control
*
Day (post-induction)
C
li
n
ic
a
l 
S
c
o
re
Figure 13. Pre-induction forced-exercise attenuates severe EAN. Sedentary (open 
circles) or forced-exercise (closed circles) trained rats were immunized with P2 peptide 
fragment by injection in the hind left footpad at day 0 and were clinically evaluated for 
signs of severe EAN. An adjuvant immunization control group (CFA control, open 
squares) is shown for comparison. Data shown are the means + SEM (n = 5-24). *p<0.05 
vs. sedentary, Mann-Whitney non-parametric U-test. 
 
Table 3. Effect of pre-induction forced-exercise on development and clinical 
severity of severe EAN induced by injection in the hind left footpad. 
 Severe EAN 
 
Sedentary 
(n = 12-24) 
Forced-exercise 
(n = 11-21) 
Clinical onset 
(post-induction day) 
12.33 (12) ± 0.20 12.64 (12.5) ± 0.22 
Clinical peak 
(post-induction day) 
17.00 (17.5) ± 0.33 15.70 (16) ± 0.15* 
Peak clinical score 3.99 (4.25) ± 0.20 2.74 (2.83) ± 0.32* 
Data shown are the means (median) + SEM. Clinical onset is defined as the first day a 
minimum clinical score of 0.5 was reached. Clinical peak is defined as the first day a 
clinical peak score was reached. *p<0.05 vs. sedentary, Mann-Whitney non-parametric 
U-test. EAN, experimental autoimmune neuritis. 
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Figure 14. Pre-induction forced-exercise attenuates severe EAN-induced loss of 
body weight. Rats randomized to sedentary (open circles) or forced-exercise (closed 
circles) were immunized with P2 peptide fragment by injection in the left hind footpad at 
day 0 and were clinically evaluated for signs of EAN. An adjuvant immunization control 
group (CFA control, open squares) is shown for comparison. Rats randomized to the 
sedentary or forced-exercise groups both lost body weight beginning on post-induction 
day 10. Data shown are the means + SEM (n = 5-24). *p<0.05 vs. sedentary control; two-
way repeated measures ANOVA with post hoc Holm-Sidak multiple comparison test.  
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development and severity of severe EAN in Lewis rats may involve exercise-dependent 
increases in circulating levels of the stress hormone, corticosterone (Moraska et al., 2000; 
Weishaupt et al., 2001; Ploughman et al., 2005; Brown et al., 2007; Ploughman et al., 
2007; Ke et al., 2011). The content of corticosterone and corticosterone-binding globulin 
(CBG) (Figure 15) in plasma prepared from blood were quantified as described within 
Material and Methods (Figure 6) between 0500 and 0800 hours.  
Adjuvant control rats or sedentary or forced-exercise EAN rats were sacrificed by 
CO2 asphyxiation either at post-induction day 14 or at post-induction day 18. Resting 
levels of plasma corticosterone content in rats immunized with CFA without P2 peptide 
(CFA control) were 71 ± 14 ng/ml (n = 6; post-injection day 14) and 177 ± 68 ng/ml (n = 
5; post-injection day 18), consistent with previously reported values for adult male Lewis 
rats at rest (Dhabhar et al., 1995; Martin et al., 2000; Duclos et al., 2001). By comparison, 
circulating corticosterone levels in sedentary EAN rats were not significantly elevated at 
post-induction day 14 (116 ± 51 ng/ml, n = 6) or day 18 (140 ± 62 ng/ml, n = 6) (Figure 
15A). Interestingly, subjecting Lewis rats to pre-induction forced-exercise prior to severe 
EAN induction did not appear to alter circulating corticosterone content at post- induction 
day 14 (91 ± 29 ng/ml, n = 6) or day 18 (138 ± 57 ng/ml, n = 5) (Figure 15A). No 
statistical differences in the content of plasma corticosterone were observed between 
sedentary and forced-exercise EAN rats [F1, 19 = 0.06, p = 0.80] and between post- 
induction days 14 and day 18 [F1, 19 = 0.47, p = 0.50] for circulating corticosterone. 
A limitation to quantifying circulating levels of corticosterone is its known 
diurnal variation (Fediuc et al., 2006) and its propensity to change rapidly in response to 
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Figure 15. Effect of pre-induction forced-exercise on circulating corticosterone and 
CBG content. Plasma corticosterone (A) and corticosterone-binding globulin (CBG) (B) 
content were quantified as described within Methods and Materials. Adjuvant (CFA 
control) immunization control (gray bars), sedentary (white bars) or forced-exercise 
(black bars) rats with severe EAN were sacrificed by CO2 asphyxiation at post-induction 
day 14 or day 18. Data shown are the means + SEM (n = 4-6). These data were analyzed 
by two-way repeated measures ANOVA with post hoc Holm-Sidak multiple comparison 
test and were found to be statistically indistinguishable.  
A. 
B. 
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environmental challenges such as exercise (Moraska et al., 2000; Ploughman et al., 2005; 
Brown et al., 2007; Ploughman et al., 2007; Ke et al., 2011). To determine if pre-
induction forced-exercise training used in this study chronically alters steady state levels 
in corticosterone content, we quantified circulating levels of the carrier protein CBG 
(Westphal, 1971; Moraska et al., 2000; Brown et al., 2007). When circulating 
corticosterone is bound to CBG, the bound corticosterone cannot interact with its 
receptor. A reduction in plasma CBG content would therefore suggest a net increase in 
free circulating corticosterone that is able to interact with its receptor. As shown in 
Figure 15B, the content of CBG in plasma of adjuvant (CFA control) immunized rats at 
post-injection day 14 and day 18 were 162 ± 22 nM (n = 6) and 73 ± 13 nM (n = 5), 
respectively. This is consistent with previously published values for adult male Lewis rats 
at rest (Dhabhar et al., 1995). By comparison, circulating levels of CBG in sedentary 
EAN rats at post-induction day 14 (140 ± 41 nM, n = 6) and day 18 (144 ± 50 nM, n = 6) 
were similar to CFA controls (Figure 15B). Pre-induction forced-exercise did not alter 
CBG content in severe EAN rats at post-induction day 14 (138 ± 23 nM, n = 6) and day 
18 (54 ± 4 nM, n = 4) (Figure 15B). Similar to plasma corticosterone, there were no 
differences in circulating CBG content between sedentary and forced-exercise EAN rats 
[F1, 19 = 0.56, p = 0.47], and between post-induction days 14 and 18 [F1, 19 = 0.35, p = 
0.56]. 
Collectively, these findings suggest that pre-induction forced-exercise attenuates 
the development of severe EAN in adult male Lewis rats by a mechanism that occurs 
independent of changes in circulating corticosterone content. 
58 
 
 
Effect of Pre-Induction Forced-Exercise on Severe EAN-Induced Peripheral Nerve 
Injury 
 
Previous studies demonstrate measurable deficits in peripheral nerve function 
following induction of severe EAN, supportive of an autoimmune-mediated 
inflammatory demyelinating nerve injury (Gabriel et al., 1997; Taylor and Pollard, 2001, 
2003; Lin et al., 2007; Sarkey et al., 2007). Whereas pre-induction forced-exercise 
attenuates the clinical severity of severe EAN (Figure 13), we next determined whether 
the pre-induction moderate training program used in this study would alter severe EAN-
induced changes in peripheral nerve large-fiber function in Lewis rats. The effect of pre-
induction forced-exercise on peripheral nerve function was determined by evoked-
response electrophysiology as described within Methods and Materials (Figure 6). 
Sedentary control rats with severe EAN at post-induction day 18 (Figure 16) 
exhibited a marked reduction in both ankle- (2.60 ± 0.74 mV, n = 6) [F1, 9 = 18.13, p = 
0.002] and sciatic notch- (2.20 ± 0.64 mV, n = 6) [F1, 9 = 13.95, p = 0.005] evoked 
CMAP amplitudes compared with pre-induction (day 0) responses (ankle 4.82 ± 0.38 
mV, n = 6; notch 3.91 ± 0.39 mV, n = 6). Severe EAN rats undergoing pre-induction 
forced-exercise exhibited similarly marked deficits in ankle- (3.10 ± 0.27 mV, n = 5) and 
sciatic-notch- (1.99 ± 0.29 mV, n = 5) evoked CMAP amplitude responses compared 
with their respective pre-induction (day 0) responses (Figure 16). Moreover, severe EAN 
rats undergoing pre-induction forced-exercise exhibited significant decreases in R ratios 
(ratio 0.64 ± 0.03, n = 5) compared with their respective pre-induction (day 0) responses 
(ratio 0.84 ± 0.03, n = 5) and respective sedentary control responses (ratio 0.82 ± 0.11, n 
= 6) [F1, 9 = 6.21, p = 0.03] consistent with injury to peripheral nerves that is not 
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uniformly distributed in forced-exercised EAN rats (Figure 17). This has been previously 
described in patients with GBS (van der Meche et al., 1988; Harvey and Pollard, 1992; 
Lin et al., 2007; Daube and Rubin, 2009; Uncini et al., 2010). 
Additionally, severe EAN rats undergoing sedentary or pre-induction forced-
exercise training exhibited nearly identical rates of MNCV (46.94 ± 5.58 m/s, n=6) [F1, 9 
= 0.02, p = 0.88] prior to immunization (Figure 18 day 0). By comparison, sedentary 
rats with severe EAN exhibited marked slowing of MNCV (33.44 ± 1.63 m/s, n = 6) [F1, 9 
= 5.65, p = 0.01] by post-induction day 18, consistent with previously published reports 
(Sarkey et al., 2007). Forced-exercise EAN rats also experienced a similar slowing of 
MNCV (35.00 ± 1.63 m/s, n = 6), though it did not reach significance.  
Neuropathological changes in sciatic nerves from sedentary or forced-exercise 
rats with severe EAN were semi-quantified as described within Methods and Materials 
(Figure 6). Sciatic nerves harvested from sedentary and forced-exercise rats with severe 
EAN sacrificed at post-induction day 18 exhibited marked histopathological changes 
consistent with presence of inflammatory infiltrates, myelin ovoids, and axonal damage 
(Figures 19 and 20). Nerves harvested from the footpad-injected limb (2.24 ± 0.20, n = 
5) of sedentary EAN rats exhibited more neuropathological changes compared with the 
non-injected limb (1.27 ± 0.38, n = 6) (Figure 19 top and Figure 20). The same 
neuropathological changes between footpad-injected (1.58 ± 0.41, n = 5) and non- 
injected limb (0.88 ± 0.20, n = 5) was seen in forced-exercise EAN rats (Figure 19 
bottom and Figure 20). Sciatic nerves harvested from footpad-injected and non-injected 
limbs of EAN rats that underwent pre-induction forced-exercise training had lower scores   
60 
 
 
0
2
4
6
8
10
Day 0 Day 0Day 18 Day 18
Ankle Sciatic Notch
  Sedentary
  Forced-Exercise
#
#
#
#
  CFA Control
C
M
A
P
 A
m
p
li
tu
d
e
 (
m
V
)
Figure 16. Effect of pre-induction forced-exercise on evoked peripheral nerve 
conduction amplitudes in rats with severe EAN. Relative changes in peripheral nerve 
CMAP amplitudes were determined by evoke-response electrophysiology prior to and 18 
days following immunization with P2 peptide fragment by injection into in the footpad as 
described within Methods and Materials. An adjuvant-immunization control group (CFA 
control, gray bars) is shown for comparison. Data shown are the means + SEM (n = 3-6) 
of rats undergoing sedentary (white bars) or forced-exercise (black bars) training. 
#
p<0.05 vs. respective day 0 responses; two-way repeated measures ANOVA with post 
hoc Holm-Sidak multiple comparison test. 
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Figure 17. Effect of pre-induction forced-exercise on R ratios in rats with severe 
EAN. Relative changes in peripheral nerve conduction ankle and notch amplitudes were 
determined by evoke-response electrophysiology, and R ratios calculated, prior to and 18 
days following immunization with P2 peptide fragment by injection into the base of the 
tail as described within Methods and Materials. An adjuvant-immunization control group 
(CFA control, gray bars) is shown for comparison. Data shown are the means + SEM (n 
= 3-6) of rats undergoing sedentary (white bars) or forced-exercise (black bars) training. 
*p<0.05 vs. respective day 18 sedentary control responses demonstrating length-
dependent demyelination; two-way repeated measures ANOVA with post hoc Holm-
Sidak multiple comparison test. 
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Figure 18. Effect of pre-induction forced-exercise on peripheral nerve conduction 
velocity in rats with severe EAN. Peripheral nerve conduction velocities were 
calculated from the experimental data shown in Fig. 8. An adjuvant immunization control 
group (CFA control, gray bars) is shown for comparison. Data shown are the means + 
SEM (n = 3-6) of rats undergoing sedentary (white bars) or forced-exercise (black bars) 
training. 
#
p<0.05 vs. respective day 0 responses; two-way repeated measures ANOVA 
with post hoc Holm-Sidak multiple comparison test. 
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than sedentary EAN rats (Figure 19 and Figure 20); however, the neuropathological 
scores between the two groups did not differ significantly (H3, 17 = 6.76, p = 0.08). 
Collectively, these data suggest that while the pre-induction forced-exercise 
training program used in this study significantly attenuates the clinical severity of severe 
EAN; however, forced-exercise is most effective at protecting against mild EAN. 
Pre-Induction Forced-Exercise Alters Immune Cell Function in Rats with Severe 
EAN 
 
To determine whether pre-induction forced-exercise attenuates clinical severe 
EAN by altering cellular immunity, sedentary control or forced-exercise rats induced 
with severe EAN were sacrificed near disease onset (post-induction day 14) or near peak 
of disease (post-induction day 18), and splenic or nodal lymphocytes from spleen or 
popliteal lymph nodes, respectively, were harvested, purified, and analyzed as described 
within Material and Methods (Figure 6). 
Pre-Induction Forced-Exercise Promotes Lymphocyte Retention 
Significant differences in the total number of lymphocytes recovered from popliteal 
lymph nodes of sedentary or forced-exercise EAN rats were observed [F1, 27 = 6.82, p = 
0.02] (Figure 21). Near peak of severe EAN, the total number of nodal lymphocytes 
recovered from forced-exercise EAN rats was significantly greater (~2-fold) compared 
with sedentary EAN control rats (Figure 21), suggesting increased retention. Pre-
induction forced-exercise increased retention of lymphocytes near onset of severe EAN; 
however, differences between sedentary and forced-exercise groups did not reach 
statistical significance. Lymphocyte retention is summarized in Table 4. 
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Figure 19. Effect of pre-induction forced-exercise on sciatic nerve neuropathology in 
rats with severe EAN. Sciatic nerves from P2 peptide injected (left) and un-injected 
(right) hind limbs were harvested from sedentary (top) and forced-exercise (bottom) 
EAN rats near peak (post-induction day 18) of disease, and histologically processed and 
imaged as described in Materials and Methods. Scale bar (red) = 25 μm. 
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Figure 20. Pre-induction forced-exercise does not protect against severe EAN-
induced neuropathological changes in the sciatic nerves. Rats that were forced-
exercised on a treadmill (black bars) or remained sedentary (white bars) were induced 
with severe EAN in the hind left footpad. Sciatic nerves were harvested at post-induction 
day 18 and prepared as described in Materials and Methods. Two blinded observers 
scored the embedded nerves; the scores were averaged. Data shown are the means + SEM 
(n = 5-6). 
0
1
2
3
Sedentary
Forced-Exercise
Left Right
Sciatic Nerve
H
is
to
p
a
th
o
lo
g
ic
a
l 
S
c
o
re
66 
 
 
Pre-Induction Forced-Exercise Promotes P2 Peptide-Stimulated Lymphocyte 
Proliferation 
 
Lymphocytes prepared from harvested popliteal lymph nodes were assayed in 
vitro for non-specific (lectin-stimulated) and P2 peptide specific proliferation functional 
capacity as described within Methods and Material (Figure 6). Stimulation indices (SI) 
were obtained by dividing lectin- or P2-stimulated proliferation responses by media-
stimulated control proliferation responses.  
Significant differences in P2 peptide antigen stimulated proliferation of 
lymphocytes harvested from sedentary or forced-exercise EAN rats were observed [F1, 15 
= 4.55, p = 0.05]. Lymphocytes harvested near onset of disease from sedentary EAN 
control rats exhibited a ~3-fold increase in P2 peptide-stimulated indices compared with 
CFA-immunization controls (Figure 22), consistent with disease onset. Forced-exercise 
EAN P2 peptide-stimulated proliferative responses were increased by ~2.5-fold 
compared to CFA-immunization; however, these proliferative responses were not 
significantly different from sedentary EAN control P2 peptide-stimulated proliferative 
responses. This slightly blunted proliferative response may indicate that forced-exercise 
alters the innate immune cell capacity to respond to P2 peptide and to initiate 
proliferation of lymphocytes as the EAN develops. In contrast, lymphocytes harvested 
from sedentary EAN control rats near peak of disease did not retain their ability to 
respond to P2 peptide-stimulation (Figure 22), consistent with lymphocyte anergy. 
Interestingly, lymphocytes harvested from forced-exercise EAN rats retained their ability 
to respond to P2 peptide-stimulation (Figure 22). These findings suggest that pre-
induction forced-exercise retains autoreactive leukocytes to P2 peptide in the lymph 
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node.  
To determine if the effect of pre-induction forced-exercise on lymphocyte 
proliferation is selective for P2 peptide-stimulation, parallel cultures of harvested and 
prepared lymphocytes were challenged in vitro with concanavalin A (ConA). This lectin 
potently non-selectively stimulates proliferation of leukocytes through toll-like receptors 
(TLRs) (Rostami et al., 1990; Rostami and Gregorian, 1991; Stenger and Modlin, 2002; 
Toubi and Shoenfeld, 2004; MacLeod and Wetzler, 2007; Yun et al., 2007; Unitt and 
Hornigold, 2011). Our results show that nodal lymphocytes harvested and prepared from 
CFA immunization control rats exhibited a robust (~40-fold) increase in stimulation 
indices near onset and peak, respectively (Figure 23). Nodal lymphocytes harvested from 
sedentary EAN control rats responded by exhibiting a ~13-fold and ~51-fold increase in 
proliferation to ConA-stimulation at near onset and peak, respectively. In contrast, both 
near onset (~5-fold) and near peak (~6-fold) of disease, lymphocytes harvested from 
forced-exercise rats responded only minimally to ConA-stimulation (Figure 23). 
Significant differences in ConA-stimulated lymphocyte proliferation were observed 
between sedentary EAN rats versus forced-exercise EAN rats [F1, 16 = 5.24, p = 0.04]. No 
differences, however, were observed between respective groups when comparing near 
onset and near peak, respectively [F1, 16 = 2.95, p = 0.11]. Post hoc tests confirmed 
significant decrease in ConA-stimulated proliferative responses of forced-exercise EAN 
lymphocytes compared to sedentary EAN lymphocytes near peak of disease. Non-
selective lectin-mediated activation of lymphocytes appears compromised by pre- 
induction forced-exercise, possibly by influencing antigen-presenting cell (APC) TLR   
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Figure 21. Pre-induction forced-exercise promotes nodal lymphocyte cell retention 
in popliteal lymph nodes. Popliteal lymph nodes were harvested from each limb and 
quantified from treated rats near onset (post-induction day 14) or near peak of disease 
(post-induction day 18) as described within Methods and Materials. Data shown are the 
means + SEM (n = 5-9) of rats undergoing sedentary (white bars) or forced-exercise 
(black bars) training prior to severe EAN induction by footpad injection. An adjuvant 
immunization control group (CFA control, gray bars) is shown for comparison. *p<0.05 
vs. sedentary EAN controls; two-way ANOVA with post-hoc Holm-Sidak multiple 
comparison analysis. 
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Figure 22. Pre-induction forced-exercise promotes functional retention of P2 
peptide-stimulated lymphocyte proliferation. Popliteal lymph nodes were harvested 
from treated rats near onset (post-induction day 14) or near peak of disease (post-
induction day 18) and P2 peptide-stimulated lymphocyte stimulation indices determined 
in vitro as described within Methods and Materials. Data shown are the means + SEM (n 
= 5-6) of rats undergoing sedentary (white bars) or forced-exercise (black bars) training 
prior to EAN induction by footpad injection. An adjuvant immunization control group 
(CFA control, gray bars) is shown for comparison. *p<0.05 vs. sedentary EAN controls; 
two-way ANOVA with post-hoc Holm-Sidak multiple comparison analysis. 
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Figure 23. Pre-induction forced-exercise attenuates lectin-stimulated lymphocyte 
proliferation. Popliteal lymph nodes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and concanavalin A 
(ConA)-stimulated lymphocyte stimulation indices determined in vitro as described 
within Methods and Materials. Data shown are the means + SEM (n = 5-6) of rats 
undergoing sedentary (white bars) or forced-exercise (black bars) training prior to severe 
EAN induction by footpad injection. An adjuvant immunization control group (CFA 
control, gray bars) is shown for comparison. *p<0.05 vs. sedentary EAN controls; two-
way ANOVA with post-hoc Holm-Sidak multiple comparison analysis. 
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dependence of lymphocyte proliferation (Flynn and McFarlin, 2006). Stimulated 
lymphocyte proliferation is summarized in Table 4. 
Pre-Induction Forced-Exercise Promotes Splenic Lymphocyte Retention 
Immune responses of localized nodal lymphocytes may differ from splenic 
lymphocytes. To determine if pre-induction forced-exercise alters splenic immune 
responses, spleens were harvested from treated rats and splenic lymphocytes prepared as 
described within Methods and Materials (Figure 6). When normalized to spleen wet 
weight, significant differences in total recovered splenic lymphocytes were observed 
between sedentary or forced-exercise EAN rats [F1, 34 = 10.40, p = 0.003]. The wet 
weights of spleens harvested between experimental groups were not statistically different 
[F1, 33 = 0.19, p = 0.67]. Near onset of disease, the total number of splenic lymphocytes 
recovered from spleens harvested from sedentary EAN rats was approximately 20% less 
compared with spleens from CFA immunization control or forced-exercised EAN rats 
(Figure 24). A similar trend in recovered splenic lymphocyte count was seen from 
spleens harvested near peak of disease. These data support the thesis that pre-induction 
forced-exercise promotes retention of lymphocytes in secondary lymphoid organs. 
Splenic lymphocyte retention is summarized in Table 4. 
Pre-Induction Forced-Exercise Preserves Lectin-Stimulated Splenic Lymphocyte 
Proliferation 
 
Splenic lymphocytes prepared from harvested spleens were assayed in vitro for 
non-specific (lectin-stimulated) and P2 peptide specific proliferation functional capacity 
as described within Methods and Material (Figure 6). Stimulation indices (SI) were 
obtained by dividing lectin- or P2-stimulated proliferation responses by media-stimulated 
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control proliferation responses.  
In marked contrast to nodal lymphocytes (Figure 22), splenic lymphocytes 
prepared from spleens harvested from CFA immunized control, sedentary or forced-
exercise EAN rats were found to be largely un-responsive to P2 peptide-stimulation 
(stimulation index 1.11 ± 0.09, n = 48; combined from all groups), possibly due to 
inefficient antigen presentation by APCs (DeFranco et al., 2007). 
By comparison, significant differences in ConA-stimulated proliferation of 
splenic lymphocytes harvested from sedentary or forced-exercise EAN rats were 
observed [F1, 33 = 17.33, p < 0.001]. Splenic lymphocytes harvested near onset or near 
peak of disease from sedentary EAN control rats exhibited a similar proliferative 
response to ConA compared with splenic lymphocytes from CFA-immunization controls 
(Figure 25). In contrast, splenic lymphocytes harvested from forced-exercise EAN rats 
near onset or near peak of disease exhibited a ~2-fold increase in stimulation indices 
compared with splenic lymphocytes from sedentary EAN control rats (Figure 25). In 
marked difference to nodal lymphocytes, these data suggest that pre-induction forced- 
exercise promotes retention (Figure 24) and preserves proliferative functional capacity 
(Figure 25) of splenic lymphocytes. Stimulated splenic lymphocyte proliferation is 
summarized in Table 4. 
Effect of Pre-Induction Forced-Exercise on Nodal Leukocyte Cytokine Production 
To further elucidate the influence of forced-exercise on immune cell function, we 
characterized the cytokine profile of nodal-derived leukocytes. We chose to evaluate 
representative pro-inflammatory (IL-2, IL-6, IFN-γ, TNF-α) and anti-inflammatory  
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Figure 24. Pre-induction forced-exercise promotes retention of splenic lymphocytes. 
Spleens were harvested from treated rats near onset (post-induction day 14) or near peak 
of disease (post-induction day 18), weighed, and total recovered splenic lymphocytes 
quantified as described within Methods and Materials. Data shown are the means + SEM 
(n = 5-19) of rats undergoing sedentary (white bars) or forced-exercise (black bars) 
training prior to severe EAN induction by footpad injection. An adjuvant immunization 
control group (CFA control, gray bars) is shown for comparison. *p<0.05 vs. sedentary 
EAN controls; two-way ANOVA with post-hoc Holm-Sidak multiple comparison 
analysis. 
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Figure 25. Pre-induction forced-exercise preserves lectin-stimulated splenic 
lymphocyte proliferation. Spleens were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and concanavalin A 
(ConA)-stimulated splenic lymphocyte stimulation indices determined in vitro as 
described within Methods and Materials. Data shown are the means + SEM (n = 5-6) of 
rats undergoing sedentary (white bars) or forced-exercise (black bars) training prior to 
severe EAN induction by footpad injection. An adjuvant immunization control group 
(CFA control, gray bars) is shown for comparison. *p<0.05 vs. sedentary EAN controls; 
two-way ANOVA with post-hoc Holm-Sidak multiple comparison analysis. 
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Table 4. Summary of retention and proliferation of nodal and splenic 
lymphocytes from pre-induction forced-exercise rats compared to sedentary 
rats sacrificed near onset or near peak of severe EAN. 
 Severe Experimental Autoimmune Neuritis 
 Popliteal Lymph Nodes Spleen 
R
et
en
ti
o
n
 
Onset - ↑ 
Peak ↑ - 
Stimulation P2 Peptide Concanavalin A P2 Peptide Concanavalin A 
P
ro
li
fe
ra
ti
o
n
 
Onset - - - ↑ 
Peak ↑ ↓ - ↑ 
Forced-exercise EAN lymphocyte retention and proliferation was compared to respective 
sedentary EAN control lymphocyte and gauged as follows: ↑, increased retention or 
proliferation; ↓, decreased retention or proliferation; -, no change.
76 
 
 
cytokines (IL-6, IL-10) released by P2 peptide-stimulated cells in vitro from leukocytes 
(Figures 26-30). Leukocytes were prepared from popliteal lymph nodes harvested from 
CFA immunized control, sedentary or forced-exercise EAN rats and cytokines 
simultaneously quantified using multiplex technology as described within Methods and 
Materials (Figure 6). 
Pre-Induction Forced-Exercise Alters Nodal Leukocyte IL-2 Cytokine Production 
IL-2 is a proliferative cytokine used in the differentiation of pro-inflammatory Th1 
cells and anti-inflammatory Th2 and Treg cells (La Cava, 2008; Zhu and Paul, 2008). The 
content of IL-2 detected was significantly different in the culture media of un-stimulated 
(quiescent) leukocytes prepared from nodes harvested from sedentary or forced-exercise 
EAN rats near onset or peak of disease (Figure 26) [F1, 16 = 4.85, p = 0.04]. Near disease 
peak, there was a significant decrease in IL-2 content from sedentary EAN leukocytes 
compared to forced-exercise EAN leukocytes. 
Due to changes in proliferative functional capacity (Figure 22), P2 peptide-
stimulated IL-2 production differed significantly from leukocytes prepared from nodes 
harvested from sedentary or forced-exercise EAN rats near onset or peak of disease 
(Figure 26) [F1, 16 = 22.54, p < 0.001]. IL-2 production near disease onset was 
significantly decreased, and significantly increased near disease peak, in forced-exercise 
EAN leukocytes (38 ± 13 pg/ml and 98 ± 13 pg/ml, n = 5, respectively) compared to 
sedentary EAN leukocytes (87 ± 9 pg/ml and 31 ± 14 pg/ml, n = 5, respectively). The 
decrease of IL-2 production near onset corresponds with a blunted proliferative capacity 
of forced-exercise lymphocytes near disease onset. Moreover, the increase of IL-2 
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production near peak corresponds with increased proliferative capacity of forced-exercise 
lymphocytes near disease peak. Non-selective activation of nodal leukocytes with ConA 
elicited a marked 10-fold increase in IL-2 production that was unaffected by forced-
exercise or disease course (Figure 26) [F1, 16 = 0.37, p = 0.55; F1, 16 = 0.56, p = 0.47]. 
Pre-Induction Forced-Exercise Does Not Alter Nodal Leukocyte P2 Peptide-Stimulated 
IL-6 Cytokine Production 
 
IL-6 is a cytokine released from leukocytes that can induce pro-inflammatory or 
anti-inflammatory differentiation of adaptive immune cells depending on the presence of 
other pro-inflammatory or anti-inflammatory cytokines (Nielsen and Pedersen, 2008; Zhu 
and Paul, 2008). IL-6 is increased in leukocyte proliferation assays from EAN rats (Bai et 
al., 1997; Zhang et al., 2008a; Zhang et al., 2009a). There were minimal un-stimulated 
(quiescent) and stimulated levels of IL-6 production from adjuvant control rats compared 
to severe EAN rats (Figure 27). In contrast to IL-2, resting levels of IL-6 released near 
onset or near peak of disease by nodal leukocytes prepared from nodes harvested from 
sedentary EAN rats were not different [F1, 16 = 1.26, p = 0.28] compared to nodal 
leukocytes prepared from nodes harvested from forced-exercise EAN rats, and were 
unaffected by disease course[F1, 16 = 0.72, p = 0.41] (Figure 27). Stimulating these 
prepared leukocytes with P2 peptide did not change the release of IL-6 between sedentary 
control and forced-exercise EAN rats [F1, 16 = 0.60, p = 0.45], or between near disease 
onset or peak [F1, 16 = 1.23, p = 0.20] (Figure 27). Changes in nodal leukocyte IL-6 
release elicited by ConA were unaffected by forced-exercise or disease course [F1, 16 = 
0.00, p = 0.95; F1, 16 = 0.02, p = 0.50]. 
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Pre-Induction Forced-Exercise Markedly Enhances Nodal Lymphocyte IL-10 Production 
IL-10 is an anti-inflammatory cytokine released from Th2, regulatory T cells, and 
sometimes Th1 cells (Belkaid and Oldenhove, 2008; La Cava, 2008; Zhu and Paul, 2008). 
There were minimal levels of IL-10 production from un-stimulated (quiescent) and 
stimulated lymphocytes prepared from nodes harvested from adjuvant control rats 
compared to severe EAN rats (Figure 28), and the content of IL-10 detected in the 
culture media of un-stimulated (quiescent) lymphocytes were similar to previously 
published findings (Yun et al., 2007). The content of IL-10 detected in the culture media 
of un-stimulated (quiescent) lymphocytes prepared from nodes harvested from sedentary 
and forced-exercise EAN rats were indistinguishable [F1, 16 = 3.33, p = 0.09], and 
unaffected by disease course [F1, 16 = 1.89, p = 0.19]. The content of IL-10 detected in 
the culture media of P2 peptide-stimulated lymphocytes prepared from nodes harvested 
from sedentary and forced-exercise EAN rats were markedly different [F1, 14 = 4.61, p = 
0.05], and affected by disease course [F1, 14 = 7.34, p = 0.02]. P2 peptide-stimulation 
increased levels of IL-10 released by nodal lymphocytes prepared from forced -exercise 
EAN rats near disease onset (2904 ± 949 pg/ml, n = 5) by ~3-fold compared with 
sedentary EAN controls (939 ± 427 pg/ml, n = 5) (Figure 28). However, only measurable 
levels of P2 peptide-stimulated IL-10 production from severe EAN rats were detected 
from lymphocytes harvested near peak of disease, consistent with antigen-stimulated cell 
anergy. A similar enhancement [F1, 15 = 18.30, p < 0.001) of ConA-stimulated 
lymphocyte production of IL-10 by forced-exercise (5304 ± 306 pg/ml, n = 4) was 
observed compared with sedentary controls (2011 ± 699 pg/ml, n = 5) (Figure 28) that 
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was unaffected by disease course [F1, 15 = 1.81, p = 0.20]. 
Pre-Induction Forced-Exercise Prolongs Nodal Leukocyte P2 Peptide-Stimulated IFN-γ 
Production 
 
IFN-γ is a cytokine released from leukocytes that induces differentiation of pro-
inflammatory Th1 cells (Zhu and Paul, 2008) and is increased in leukocyte proliferation 
assays from severe EAN rats (Bai et al., 1997; Zhang et al., 2008a; Zhang et al., 2009a). 
There were minimal levels of IFN-γ production from un-stimulated (quiescent) and 
stimulated lymphocytes prepared from nodes harvested from adjuvant control rats 
compared to severe EAN rats (Figure 29), and the content of IFN-γ detected in the 
culture media of un-stimulated (quiescent) lymphocytes were similar to previously 
published findings (Yun et al., 2007). Resting [F1, 16 = 0.38, p = 0.55] and P2 peptide-
stimulated [F1, 15 = 3.52, p = 0.08] levels of IFN-γ from sedentary and forced-exercised 
leukocytes were unaffected by disease course (Figure 29). Resting levels of this pro-
inflammatory cytokine in media of nodal leukocytes harvested from forced-exercise EAN 
rats was markedly elevated by ~8-fold (333 ± 95 pg/ml, n = 5) compared to sedentary 
EAN controls (42 ± 12 pg/ml, n = 5) [F1, 16 = 10.20, p = 0.01] near disease onset. 
Leukocytes from sedentary or forced-exercise EAN rats near disease onset exhibited a 
robust IFN-γ response (6828 ± 3161 pg/ml and 11298 ± 3943 pg/ml, n = 5, respectively) 
to P2 peptide antigen stimulation; however, there were no difference between these two 
groups [F1, 15 = 4.09, p = 0.06] (Figure 29). Near peak of disease, leukocytes from 
sedentary EAN control rats were unresponsive to subsequent P2 peptide-stimulation (68 
± 53 pg/ml, n = 4) compared to forced-exercise EAN rats (7247 ± 1942 pg/ml, n = 5); 
however, the difference does not reach significance [F1, 15 = 4.09, p = 0.06]. This trend 
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can suggest that nodal leukocytes from forced-exercise EAN rats retained their ability to 
respond to P2 peptide-stimulation. 
Pre-Induction Forced-Exercise Does Not Alter Nodal Leukocyte TNF-α Cytokine 
Production 
 
TNF-α is a pro-inflammatory cytokine released from leukocytes (Leung et al., 
2008) and is increased in leukocyte proliferation assays from EAN rats (Bai et al., 1997; 
Zhang et al., 2008a; Zhang et al., 2009a). The content TNF-α detected was not different 
in the culture media of un-stimulated (quiescent) leukocytes prepared from nodes 
harvested from sedentary or forced-exercise EAN rats near disease onset and was largely 
unaffected by disease course (Figure 30) [group: F1, 16 = 0.07, p = 0.80; time: F1, 16 = 
0.05, p = 0.83]. TNF-α production elicited by nodal leukocytes from sedentary (24 ± 6 
pg/ml, n = 5) or forced-exercise (34 ± 9 pg/ml, n = 5) EAN rats near disease onset 
stimulated by P2 peptide was not significantly different [F1, 16 = 3.00, p = 0.10] (Figure 
30). Leukocytes harvested near peak of disease from sedentary or forced- exercise EAN 
control rats exhibited reduced levels P2 peptide-stimulated TNF-α compared near onset 
[F1, 16 = 4.79, p = 0.04]; however post hoc tests failed to reveal any significance. Non-
selective activation of nodal leukocytes with ConA elicited no alterations in TNF-α 
production between EAN groups [F1, 15 = 1.10, p = 0.31] that was also unaffected by 
disease course [F1, 15 = 1.80, p = 0.20] (Figure 30). 
Released cytokine changes from nodal leukocytes are summarized in Table 5. 
Effect of Pre-Induction Forced-Exercise on Splenic Leukocyte Cytokine Production 
 
To determine the influence of pre-induction forced-exercise on splenic immune 
cell function, we characterized the cytokine profile of spleen-derived leukocytes (Figures 
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Figure 26. Pre-induction forced-exercise alters nodal leukocyte resting or P2 
peptide-stimulated IL-2 production. Popliteal lymph nodes were harvested from treated 
rats near onset (post-induction day 14) or near peak of disease (post-induction day 18) 
and resting (un-stimulated), P2 peptide-, or concanavalin A-stimulated leukocyte IL-2 
cytokine production and/or release were quantified in vitro as described within Methods 
and Materials. Data shown are the means + SEM (n = 5) of rats undergoing sedentary 
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by 
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is 
shown for comparison. *p<0.05 vs. respective sedentary EAN controls, 
#
p<0.05 vs. 
respective post-induction day 14 values, two-way ANOVA with post hoc Holm-Sidak 
multiple comparison analysis. 
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Figure 27. Pre-induction forced-exercise does not alter nodal leukocyte IL-6 
production. Popliteal lymph nodes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and resting (un-
stimulated), P2 peptide-, or concanavalin A-stimulated leukocyte IL-6 cytokine 
production and/or release were quantified in vitro as described within Methods and 
Materials. Data shown are the means + SEM (n = 5) of rats undergoing sedentary (white 
bars) or forced-exercise (black bars) training prior to severe EAN induction by footpad 
injection. An adjuvant immunization control group (CFA control, gray bars) is shown for 
comparison. These data were analyzed by two-way ANOVA with post hoc Holm-Sidak 
multiple comparison test and were found to be statistically indistinguishable. 
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Figure 28. Pre-induction forced-exercise enhances nodal lymphocyte antigen- and 
lectin-stimulated IL-10 production. Popliteal lymph nodes were harvested from treated 
rats near onset (post-induction day 14) or near peak of disease (post-induction day 18) 
and resting (un-stimulated), P2 peptide-, or concanavalin A-stimulated lymphocyte IL-10 
cytokine production and/or release were quantified in vitro as described within Methods 
and Materials. Data shown are the means + SEM (n = 4-5) of rats undergoing sedentary 
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by 
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is 
shown for comparison. *p<0.05 vs. respective sedentary EAN controls, 
#
p<0.05 vs. 
respective post-induction day 14 values; two-way ANOVA with post hoc Holm-Sidak 
multiple comparison analysis. 
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Figure 29. Pre-induction forced-exercise prolongs nodal leukocyte P2 peptide-
stimulated IFN-γ production. Popliteal lymph nodes were harvested from treated rats 
near onset (post-induction day 14) or near peak of disease (post-induction day 18) and 
resting (un-stimulated), P2 peptide-, or concanavalin A-stimulated leukocyte IFN-γ 
cytokine production and/or release were quantified in vitro as described within Methods 
and Materials. Data shown are the means + SEM (n = 4-5) of rats undergoing sedentary 
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by 
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is 
shown for comparison. *p<0.05 vs. respective sedentary EAN controls; two-way 
ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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Figure 30. Pre-induction forced-exercise does not alter nodal leukocyte TNF-α 
production. Popliteal lymph nodes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and resting (un-
stimulated), P2 peptide-, or concanavalin A-stimulated leukocyte TNF-α cytokine 
production and/or release were quantified in vitro as described within Methods and 
Materials. Data shown are the means + SEM (n = 4-5) of rats undergoing sedentary 
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by 
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is 
shown for comparison. These data were analyzed by two-way ANOVA with post hoc 
Holm-Sidak multiple comparison test and were found to be statistically indistinguishable. 
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31-35). We once again evaluated representative pro-inflammatory (IL-2, IL-6, IL-12p70, 
IFN-γ, TNF-α) and anti-inflammatory cytokines (IL-4, IL-6, IL-10) released by splenic 
lymphocytes in vitro. Splenic lymphocytes were prepared from spleens harvested from 
CFA immunized control, sedentary or forced-exercise EAN rats and cytokines 
simultaneously quantified using multiplex technology as described within Methods and 
Materials (Figure 6).  
Resting Splenic Leukocyte Cytokine Levels 
Despite measurable changes in lectin-stimulated cell proliferation (Figure 25), we 
were unable to detect resting or P2 peptide-stimulated changes in splenic lymphocyte 
production of IL-4 or IL-12p70 among spleens harvested from CFA immunization 
control, sedentary or forced-exercise EAN rats. 
Culturing resting splenic lymphocytes harvested from sedentary or forced-
exercise EAN rats near onset or near peak of disease did not significantly alter levels of 
IL-2 (Figure 31) [group: F1, 8 = 0.83, p = 0.39; time: F1, 8 = 0.22, p = 0.65], IL-10 
(Figure 33) [group: F1, 20 = 2.51, p = 0.13; time: F1, 20 = 0.11, p = 0.74], or IFN-γ 
(Figure 34) [group: F1, 19 = 1.05, p = 0.32; time: F1, 19 = 2.42, p = 0.14), or TNF-α 
(Figure 35) [group: F1, 20 = 0.93, p = 0.35; time: F1, 20 = 1.66, p = 0.21). 
A significant effect of group was observed for resting levels of IL-6 [F1, 20 = 5.47, 
p = 0.03], but a post-hoc analysis suggested no significance between experimental groups 
(Figure 32). Disease course had no effect for resting levels of IL-6 [F1, 20 = 2.15, p = 
0.16]. These statistical findings suggest that changes in IL-6 most likely reflect 
experimental noise due to low resting levels of this cytokine. 
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P2 Peptide-Stimulated Splenic Leukocyte Cytokine Levels 
Culturing P2 peptide-stimulated splenic lymphocytes harvested from sedentary or 
forced-exercise EAN rats near onset or near peak of disease with P2 peptide did not 
significantly alter levels of IL-2 (Figure 31) [group: F1, 8 = 3.20, p = 0.11; time: F1, 8 = 
0.47, p = 0.51] or IL-10 (Figure 33) [group: F1, 20 = 0.52, p = 0.48; time: F1, 20 = 0.79, p 
= 0.39]. 
There were no alterations of IL-6 levels from P2 peptide-stimulation of splenic 
lymphocytes from sedentary and forced-exercise EAN rats near disease onset or peak [F1, 
19 = 0.04, p = 0.84] (Figure 32). Near disease peak, however, splenic lymphocytes from 
sedentary and forced-exercise EAN rats exhibited a decrease in P2 peptide-stimulated IL-
6 production (0 ± 0 pg/ml and 6 ± 3 pg/ml, n = 6, respectively) compared with splenic 
lymphocytes from disease onset (76 ± 27 pg/ml and 62 ± 24 pg/ml, n = 6, respectively) 
[F1, 19 = 11.88, p = 0.003], indicative of immune cell anergy (Figure 32). 
P2 peptide-stimulation of splenic lymphocytes from sedentary and forced-exercise 
EAN rats harvested near disease onset failed to elicit pro-inflammatory TNF-α cytokine 
production (Figure 35). Near disease peak, however, splenic lymphocytes from forced-
exercise EAN rats exhibited a measurable P2 peptide-stimulated increase in TNF-α 
production (85 ± 36 pg/ml, n = 6) compared with splenic lymphocytes from sedentary 
EAN control rats (2 ± 0.4 pg/ml, n = 6), and from splenic lymphocytes from forced-
exercised EAN rats sacrificed at disease onset (9 ± 2 pg/ml, n = 6) [F1, 20 = 5.33, p = 
0.03]. 
In contrast to TNF-α, splenic lymphocytes harvested from sedentary or forced-
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exercise EAN rats near disease onset responded to P2 peptide-stimulation by increasing 
the release of pro-inflammatory cytokine IFN-γ (1965 ± 851 pg/ml and 1730 ± 822 
pg/ml, n = 6, respectively) (Figure 34), though there were no differences between groups 
[F1, 20 = 0.01, p = 0.92]. Near peak of disease, the IFN-γ response to P2 peptide was 
diminished in sedentary control rats (187 ± 95 pg/ml, n = 6) [F1, 20 = 7.29, p = 0.01], 
consistent with anergy of autoreactive T-cells and the beginning of disease recovery. 
There was a similar decrease near disease peak of P2-peptide stimulated splenic 
lymphocyte production of IFN-γ by forced-exercise leukocytes (298 ± 74 pg/ml, n = 6) 
compared to near onset levels (1730 ± 822 pg/ml, n = 6) [F1, 20 = 7.29, p = 0.01], 
however, post hoc tests failed to reveal significance (Figure 35).  
ConA-Stimulated Splenic Leukocyte Cytokine Levels 
Splenic lymphocytes harvested from all experimental groups responded quite 
robustly to ConA-stimulation with some unique distinctions influenced by disease course 
(Figures 31-35). Compared with resting levels, ConA elicited a ~200-fold increase in IL-
2 release from splenic lymphocytes harvested near disease onset from CFA immunization 
control rats (8468 ± 715 pg/ml, n = 4) (Figure 31). Pre-induction forced-exercise 
attenuated ConA-stimulated release of IL-2 (3928 ± 598 pg/ml, n = 3) compared to 
sedentary EAN control (6551 ± 376 pg/ml, n = 3) from splenic lymphocytes harvested 
near disease onset [F1, 11 = 10.20, p = 0.01] (Figure 31). Compared with respective onset 
values, a decrease in IL-2 production was observed [F1, 11 = 10.20, p = 0.01] near peak of 
disease for sedentary EAN control rats (4107 ± 605 pg/ml, n = 3) that was 
indistinguishable to peak forced-exercise EAN IL-2 levels, indicating anergy of sedentary 
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EAN immune cells.  
With regard to IL-6, splenic lymphocytes harvested from CFA immunization 
control rats responded to ConA-stimulation (194 ± 32 pg/ml, n = 4) by modestly 
increasing the production of this cytokine ~2-fold (Figure 32). By comparison, splenic 
lymphocytes from sedentary or forced-exercise EAN rats similarly responded to ConA-
stimulation by enhancing IL-6 release ~9-fold (538 ± 115 pg/ml and 464 ± 145, n = 6, 
respectively). Near peak of disease, splenic lymphocytes from sedentary EAN rats (33 ± 
15 pg/ml, n = 6) exhibited marked reduction in ConA-stimulated IL-6 release compared 
with respective onset values [F1, 20 = 11.21, p = 0.003] (Figure 32).  
Similar to IL-2, ConA elicited a marked ~15-fold release of TNF-α from splenic 
lymphocytes harvested near disease onset from all three experimental groups (Figure 
35). In contrast, splenic lymphocytes from sedentary EAN control rats harvested near 
peak of disease responded only marginally (4 ± 1 pg/ml, n = 6) to ConA-stimulation 
compared with splenic lymphocytes harvested onset sedentary (191 ± 27 pg/ml, n = 6) or 
from peak forced-exercise (169 ± 19 pg/ml, n = 6) EAN rats (Figure 35) [F1, 20 = 9.33, p 
= 0.01]. 
Pre-induction forced-exercise had little effect on ConA-stimulated release of IL-
10 from splenic lymphocytes as shown in Figure 33. Splenic lymphocytes harvested near 
onset of disease from sedentary (1585 ± 246 pg/ml, n = 6) and forced-exercise (1838 ± 
360 pg/ml, n = 6) EAN rats did not differ significantly [F1, 20 = 1.61, p = 0.21]. This 
response was affected by disease course [F1, 20 = 8.07, p = 0.01], with peak sedentary 
EAN IL-10 production (684 ± 327 pg/ml, n = 6) decreasing compared to onset sedentary 
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EAN. However, this is probably attributed to experimental noise. 
Released cytokine changes from splenic lymphocytes are summarized in Table 5. 
Effect of Pre-Induction Forced-Exercise on severe EAN-Induced T Cell Bias 
Changes in nodal autoreactive lymphocyte cytokine profiling with pre-induction 
forced-exercise (Figures 28 and 29) suggest a possible localized shift from pro- 
inflammatory type 1 helper T (Th1) cellular immunity toward a more protective type 2 
helper T (Th2) cellular immune response. To determine if pre-induction forced-exercise 
influences T cell bias, spleens and popliteal lymph nodes were harvested from severe 
EAN rats and prepared splenic and nodal lymphocytes, respectively, and lymphocytes 
obtained from blood collected from severe EAN rats, were fluorescently labeled as 
described within Methods and Materials (Figure 6). Using flow cytometry (Figure 36), 
relative changes in the percent distribution of helper T (Th), Th1, Th2, cytotoxic T (Tc), or 
activated Tc cells were quantified. 
Pre-Induction Forced-Exercise Attenuates Severe EAN-Induced Nodal Th1 Cell Bias 
The total percent distribution of helper T cells (Figure 37) recovered from 
popliteal lymph nodes harvested from sedentary or forced-exercise EAN rats was 
statistically indistinguishable [F1, 28 = 3.27, p = 0.08] and unaffected by disease course 
[F1, 28 = 0.05, p = 0.83], demonstrating that pre-induction forced-exercise does not by 
itself alter localized helper T cell distribution. 
By comparison, the percent distribution of Th1 cells present in nodes harvested 
near disease onset from sedentary EAN control rats was found to be significantly [F1, 28 
=6.57, p = 0.02] elevated (5.10 ± 0.87 %, n = 8) compared with forced-exercise EAN  
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Figure 31. Pre-induction forced-exercise attenuates splenic lymphocyte lectin-
stimulated IL-2 production. Splenic lymphocytes were harvested from treated rats near 
onset (post-induction day 14) or near peak of disease (post-induction day 18) and resting 
(un-stimulated), P2 peptide-, or concanavalin A (ConA)-stimulated splenic lymphocyte 
IL-2 cytokine production and/or release were quantified in vitro as described within 
Methods and Materials. Data shown are the means + SEM (n = 3-4) of rats undergoing 
sedentary (white bars) or forced-exercise (black bars) training prior to severe EAN 
induction by footpad injection. An adjuvant immunization control group (CFA control, 
gray bars) is shown for comparison. *p<0.05 vs. respective sedentary EAN controls, 
#
p<0.05 vs. respective post induction day 14 values; two-way ANOVA with post hoc 
Holm-Sidak multiple comparison analysis. 
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Figure 32. Pre-induction forced-exercise alters splenic lymphocyte lectin-stimulated 
IL-6 production. Splenic lymphocytes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and resting (un-
stimulated), P2 peptide-, or concanavalin A (ConA)-stimulated splenic lymphocyte IL-6 
cytokine production and/or release were quantified in vitro as described within Methods 
and Materials. Data shown are the means + SEM (n = 4-6) of rats undergoing sedentary 
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by 
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is 
shown for comparison. 
#
p<0.05 vs. respective post induction day 14 values; two-way 
ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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Figure 33. Pre-induction forced-exercise does not alter splenic lymphocyte IL-10 
production. Splenic lymphocytes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and resting (un-
stimulated), P2 peptide-, or concanavalin A (ConA)-stimulated splenic lymphocyte IL-10 
cytokine production and/or release were quantified in vitro as described within Methods 
and Materials. Data shown are the means + SEM (n = 4-6) of rats undergoing sedentary 
(white bars) or forced-exercise (black bars) training prior to severe EAN induction by 
footpad injection. An adjuvant immunization control group (CFA control, gray bars) is 
shown for comparison. 
#
p<0.05 vs. respective post induction day 14 values; two-way 
ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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Figure 34. Pre-induction forced-exercise does not alter splenic lymphocyte IFN-γ 
production. Splenic lymphocytes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and resting (un-
stimulated) or P2 peptide-stimulated splenic lymphocyte IFN-γ cytokine production 
and/or release were quantified in vitro as described within Methods and Materials. Data 
shown are the means + SEM (n = 4-6) of rats undergoing sedentary (white bars) or 
forced-exercise (black bars) training prior to severe EAN induction by footpad injection. 
An adjuvant immunization control group (CFA control, gray bars) is shown for 
comparison. 
#
p<0.05 vs. respective post induction day 14 values; two-way ANOVA with 
post hoc Holm-Sidak multiple comparison analysis. 
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Figure 35. Pre-induction forced-exercise enhances splenic lymphocyte P2 peptide- 
and lectin-stimulated TNF-α production. Splenic lymphocytes were harvested from 
treated rats near onset (post-induction day 14) or near peak of disease (post-induction day 
18) and resting (un-stimulated), P2 peptide-, or concanavalin A (ConA)-stimulated 
splenic lymphocyte TNF-α cytokine production and/or release were quantified in vitro as 
described within Methods and Materials. Data shown are the means + SEM (n = 4-6) of 
rats undergoing sedentary (white bars) or forced-exercise (black bars) training prior to 
severe EAN induction by footpad injection. An adjuvant immunization control group 
(CFA control, gray bars) is shown for comparison. *p<0.05 vs. respective sedentary 
EAN controls,
 #
p<0.05 vs. respective post induction day 14 values; two-way ANOVA 
with post hoc Holm-Sidak multiple comparison analysis. 
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rats (2.91 ± 0.55 %, n = 8) (Figure 38). Near disease peak, the percentage of Th1 cells 
was still elevated in nodes harvested from sedentary EAN control rats (4.15 ± 0.70 %, n = 
8) [F1, 28 = 0.40, p = 0.53] (Figure 38). 
Pre-Induction Forced-Exercise Does Not Affect Nodal Th2 Cell Bias 
In marked difference to Th1 cell bias, no statistical distinctions were apparent between the 
percent distribution of Th2 cells present in nodes harvested from sedentary and forced-
exercise EAN groups [F1, 19 = 2.60, p = 0.12]; however, there was a statistical distinction 
in lymphocyte percentage between near onset and peak of disease in forced-exercise 
EAN rats [F1, 19 = 5.78, p = 0.03] (Figure 39). This slight increase in Th2 cells obtained 
from peak forced-exercise EAN rats was indistinguishable from peak sedentary EAN 
rats. These findings strongly suggest that pre-induction forced-exercise does not protect 
against the clinical development of severe EAN by a mechanism involving a localized 
Th1/Th2 shift in the cell bias of autoreactive lymphocytes, but instead decreasing the pro-
inflammatory Th1 response. 
Pre-Induction Forced-Exercise Does Not Affect Nodal Tc Cells 
The total percent distribution of Tc cells (Figure 40) recovered from popliteal 
lymph nodes harvested from sedentary or forced-exercise EAN rats was statistically 
indistinguishable [F1, 16 = 0.17, p = 0.68] and unaffected by disease course [F1, 16 = 1.32,  
p = 0.27], demonstrating that pre-induction forced-exercise does not alter Tc cell 
distribution. 
Similarly, no effect of experimental group [F1, 16 = 0.30, p = 0.59] or disease  
course [F1, 16 = 0.33, p = 0.58] was apparent regarding the percent distribution of  
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Figure 36. Representative flow cytometric dot plots of nodal T cell bias from severe 
EAN rats. Popliteal lymph nodes were harvested from sedentary or forced-exercise EAN 
rats induced in the footpad near onset of disease. Lymphocytes were identified by gating 
against the forward and side scatter (A). The percentage (red box) of Th1 cells were 
further quantified by staining cells (B, top) with fluorescently tagged monoclonal 
antibodies to cell surface markers CD4 and CD212 compared with (B, bottom) 
corresponding isotype controls. 
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activated Tc cells (Figure 40). 
Pre-Induction Forced-Exercise Attenuates Severe EAN-Induced Splenic Th1 Cell Bias 
Whereas pre-induction forced-exercise prevented a localized bias in Th1 cell 
distribution (Figure 38) consistent with a lessening of disease severity, we sought to 
determine if such a protective effect by pre-induction forced-exercise was similarly 
evident in the spleen.  
The total percent distribution of Th cells recovered from spleens harvested from 
sedentary or forced-exercise EAN rats were statistically indistinguishable [F1, 32 = 1.14, p 
= 0.29], and unaffected by disease course [F1, 29 = 0.22, p = 0.65] (Figure 40). These 
findings agree well with localized changes in nodal T cell responses (Figure 37) and 
further support the thesis that pre-induction forced-exercise does not by itself alter helper 
T cell distribution. 
Similar to that observed for nodal T cells (Figure 38), the percent distribution of 
Th1 cells present in spleens harvested near disease onset from sedentary EAN control rats 
(11.41 ± 1.47 %, n = 6) was found to be elevated compared to forced-exercise EAN rats 
(8.63 ± 0.19 %, n = 6), though failed to reach statistical significance [F1, 20 = 6.21, p = 
0.07] (Figure 43). Near disease peak, the percentage of Th1 cells in spleens harvested 
from sedentary and forced-exercise EAN rats were significantly reduced [F1, 20 = 27.09, p 
< 0.001], consistent with the beginning of disease recovery (Figure 43). 
Pre-Induction Forced-Exercise Does Not Affect Splenic Th2 Cell Bias 
No meaningful statistical distinctions were apparent between the percent 
distribution of Th2 cells present in spleens harvested from sedentary and forced-exercise 
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EAN rats [F1, 19 = 0.06, p = 0.81], and was unaffected by disease course [F1, 19 = 0.80, p 
= 0.38] (Figure 44). These splenic findings strongly suggest that pre-induction forced-
exercise does not protect against the clinical development of severe EAN by a 
mechanism involving a Th1/Th2 shift in the cell bias of autoreactive lymphocytes, but 
instead protects against a pro-inflammatory Th1 response. 
Pre-Induction Forced-Exercise Affects the Percent Distribution of Splenic Activated Tc 
cells 
 
The total percent distribution of Tc cells recovered from spleens harvested from 
sedentary or forced-exercise EAN rats (Figure 45) was statistically indistinguishable [F1, 
20 = 0.16, p = 0.69], but was affected by disease course [F2, 20 = 5.49, p = 0.03]. A 
reduction in the percent distribution of Tc cells from spleens of peak forced-exercise EAN 
rats (17.33 ± 1.11 %, n = 6) compared to onset forced-exercise EAN rats (12.77 ± 0.91%, 
n = 6) was noted, but this was most likely due to experimental noise. These findings 
suggest that pre-induction forced-exercise does not alter splenic cytotoxic T cell 
distribution.  
The effect of pre-induction forced-exercise on the percent distribution of activated 
splenic Tc cells is shown in Figure 46. Spleens harvested near disease onset from 
sedentary EAN control rats (6.07 ± 0.35 %, n = 6) exhibited an elevated percent 
distribution of activated Tc cells compared to forced-exercise EAN rats (4.86 ± 0.19 %, 
n= 6) [F1, 20 = 4.45, p = 0.05]. Near peak of disease, spleens harvested from both groups 
exhibited a similar percent distribution of activated Tc cells, and were significantly 
reduced compared to near onset of disease [F1, 20 = 67.08, p < 0.001], consistent with  
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Figure 37. Pre-induction forced-exercise does not affect nodal helper T cell bias. 
Popliteal lymph nodes were harvested from treated rats near onset (post-induction day 
14) or near peak of disease (post-induction day 18) and gated lymphocytes were stained 
with fluorescently tagged monoclonal antibody to cell surface marker CD4 or isotype 
control. Data shown are the means + SEM (n = 5-8). These data were analyzed by two-
way ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be 
statistically indistinguishable. 
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Figure 38. Pre-induction forced-exercise attenuates severe EAN-induced nodal Th1 
cell bias. Popliteal lymph nodes were harvested from treated rats near onset (post-
induction day 14) or near peak of disease (post-induction day 18) and gated lymphocytes 
were stained with fluorescently tagged monoclonal antibodies to cell surface markers 
CD4 and CD212, or isotype control. Data shown are the means + SEM (n = 5-8). 
*p<0.05 vs. sedentary EAN control; two-way ANOVA with post hoc Holm-Sidak 
multiple comparison analysis. 
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Figure 39. Pre-induction forced-exercise modestly affects nodal Th2 cell bias. 
Popliteal lymph nodes were harvested from treated rats near onset (post-induction day 
14) or near peak of disease (post-induction day 18) and gated lymphocytes were stained 
with fluorescently tagged monoclonal antibodies to cell surface markers CD4 and 
CD278, or isotype control. Data shown are the means + SEM (n = 5-6). 
#
p<0.05 vs. 
respective post induction day 14 values; two-way ANOVA with post hoc Holm-Sidak 
multiple comparison analysis. 
104 
 
 
  
0
5
10
15
20
25
30
35
Day 18Day 14
CFA Control
Sedentary
Forced-Exercise
T
c 
ce
ll
s 
(%
 o
f 
to
ta
l 
ly
m
p
h
o
cy
te
s)
Figure 40. Pre-induction forced-exercise does not affect nodal Tc cell bias. Popliteal 
lymph nodes were harvested from treated rats near onset (post-induction day 14) or near 
peak of disease (post-induction day 18) and gated lymphocytes were stained with 
fluorescently tagged monoclonal antibody to cell surface marker CD8 or isotype control. 
Data shown are the means + SEM (n = 5-6). These data were analyzed by two-way 
ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be 
statistically indistinguishable. 
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Figure 41. Pre-induction forced-exercise does not affect activated nodal Tc cell bias. 
Popliteal lymph nodes were harvested from treated rats near onset (post-induction day 
14) or near peak of disease (post-induction day 18) and gated lymphocytes were stained 
with fluorescently tagged monoclonal antibodies to cell surface markers CD8 and 
CD212, or isotype control. Data shown are the means + SEM (n = 5-6). These data were 
analyzed by two-way ANOVA with post hoc Holm-Sidak multiple comparison test and 
were found to be statistically indistinguishable. 
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Figure 42. Pre-induction forced-exercise does not affect splenic helper T cell bias. 
Spleens were harvested from treated rats near onset (post-induction day 14) or near peak 
of disease (post-induction day 18) and gated lymphocytes were stained with fluorescently 
tagged monoclonal antibody to cell surface marker CD4 or isotype control. Data shown 
are the means + SEM (n = 5-9). *p<0.05 vs. CFA immunization control; two-way 
ANOVA with post hoc Holm-Sidak multiple comparison analysis. These data were 
analyzed by two-way ANOVA with post hoc Holm-Sidak multiple comparison test and 
were found to be statistically indistinguishable. 
107 
 
 
  
0
5
10
15
Day 18Day 14
CFA Control
Sedentary
Forced-Exercise
# #
T
h
1
 c
el
ls
 (
%
 o
f 
to
ta
l 
ly
m
p
h
o
cy
te
s)
Figure 43. Pre-induction forced-exercise attenuates severe EAN-induced splenic Th1 
cell bias. Spleens were harvested from treated rats near onset (post-induction day 14) or 
near peak of disease (post-induction day 18) and gated lymphocytes were stained with 
fluorescently tagged monoclonal antibodies to cell surface markers CD4 and CD212, or 
isotype control. Data shown are the means + SEM (n = 5-6). 
#
p<0.05 vs. respective post-
induction day 14 values; two-way ANOVA with post hoc Holm-Sidak multiple 
comparison analysis. 
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Figure 44. Pre-induction forced-exercise does not affect splenic Th2 cell bias. Spleens 
were harvested from treated rats near onset (post-induction day 14) or near peak of 
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently 
tagged monoclonal antibodies to cell surface markers CD4 and CD278, or isotype 
control. Data shown are the means + SEM (n = 5-6). These data were analyzed by two-
way ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be 
statistically indistinguishable. 
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Figure 45. Pre-induction forced-exercise does not affect splenic Tc cell bias. Spleens 
were harvested from treated rats near onset (post-induction day 14) or near peak of 
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently 
tagged monoclonal antibody to cell surface marker CD8 or isotype control. Data shown 
are the means + SEM (n = 5-6). 
#
p<0.05 vs. respective post-induction day 14 values; 
two-way ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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Figure 46. Pre-induction forced-exercise does not affect activated splenic Tc cell 
bias. Spleens were harvested from treated rats near onset (post-induction day 14) or near 
peak of disease (post-induction day 18) and gated T lymphocytes were stained with 
fluorescently tagged monoclonal antibodies to cell surface markers CD8, CD212, or 
isotype control. Data shown are the means + SEM (n = 5-6). *p<0.05 vs. sedentary EAN 
control; 
#
p<0.05 vs. respective post-induction day 14 values; two-way ANOVA with post 
hoc Holm-Sidak multiple comparison analysis. 
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disease recovery. 
 
Pre-Induction Forced-Exercise Attenuates Severe EAN-Induced Circulating Th1 Cell 
Bias 
 
Whereas pre-induction forced-exercise prevented a localized and splenic bias in 
Th1 cell distribution (Figures 38 and 43) consistent with a lessening of disease severity, 
we sought to determine if such a protective effect by pre-induction forced-exercise was 
similarly evident in circulation. 
The total percent distribution of Th cells in blood collected from sedentary or 
forced-exercise EAN rats near disease onset was statistically indistinguishable [F1, 18 = 
2.21, p = 0.16] (Figure 47). By comparison, blood collected from sedentary control 
(55.97 ± 0.98 %, n = 6) and forced-exercise (57.50 ± 2.42%, n = 5) EAN rats near disease 
peak exhibited a modest increase [F1, 18 = 14.23, p = 0.001] in Th cells compared to near 
disease onset (50.87 ± 0.30 % and 53.08 ± 0.61%, n = 5-6, respectively) that was most 
likely due to return of normal immune surveillance by Th cells ] (Figure 47). These 
findings agree well with changes in nodal and splenic T cell responses (Figures 35 and 
40) and further support the thesis that pre-induction forced-exercise does not by itself 
alter helper T cell distribution. 
Similar to that observed for nodal and splenic T cells (Figure 48), the percent 
distribution of Th1 cells present in blood collected from sedentary EAN control rats was 
found to be significantly [F1, 18 = 7.61, p = 0.01] elevated compared forced-exercise EAN 
rats (Figure 48). At disease onset, sedentary (7.01 ± 0.94 %, n = 6) and forced-exercise 
(5.04 ± 0.32 %, n = 5) EAN rats had similar percentages of blood Th1 cells (Figure 48). 
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Near disease peak, the percentage of Th1 cells in blood collected from sedentary EAN 
rats (6.21 ± 0.95 %, n = 6) was sustained compared to sedentary onset levels, and 
significantly increased compared to forced-exercise EAN rats (3.58 ± 0.81 %, n = 5) 
signifying continued disease status. There was a modest reduction in Th1 cells in blood 
collected from forced-exercise EAN rats which consistent with the beginning of disease 
recovery (Figure 48). 
Pre-Induction Forced-Exercise Does Not Affect Circulating Th2 Cell Bias 
In marked difference to Th1 cell bias, no meaningful statistical distinctions were 
apparent between the percent distribution of Th2 cells present in blood collected from 
sedentary or forced-exercise EAN groups [F1, 16 = 0.59, p = 0.45] or between near onset 
or peak of disease [F1, 16 = 0.19, p = 0.67] (Figure 49). Similar to nodal and splenic 
findings (Figures 39 and 44), these circulatory findings strongly suggest that pre-
induction forced-exercise does not protect against the clinical development of severe 
EAN by a mechanism involving a Th1/Th2 shift in the cell bias of autoreactive 
lymphocytes, but instead protects against a pro-inflammatory Th1 response. 
Pre-Induction Forced-Exercise Does Not Affect Circulating Tc Cell Bias 
The total percent distribution of Tc cells recovered from blood collected from 
sedentary or forced-exercise EAN rats (Figure 50) was statistically indistinguishable[F1, 
18 = 1.38, p = 0.26], but was affected by disease course [F1, 18 = 110.0, p < 0.001]. Near 
disease peak, all groups had a ~35% decrease in Tc cell percentages compared to near 
disease onset, signifying the beginning of disease recovery.  
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Figure 47. Pre-induction forced-exercise does not affect circulating helper T cell 
bias. Blood was collected from treated rats near onset (post-induction day 14) or near 
peak of disease (post-induction day 18) and gated lymphocytes were stained with 
fluorescently tagged monoclonal antibody to cell surface marker CD4 or isotype control. 
Data shown are the means + SEM (n = 3-6). 
#
p<0.05 vs. respective post-induction day 14 
values; two-way ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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Figure 48. Pre-induction forced-exercise attenuates severe EAN-induced circulating 
Th1 cell bias. Blood was collected from treated rats near onset (post-induction day 14) or 
near peak of disease (post-induction day 18) and gated lymphocytes were stained with 
fluorescently tagged monoclonal antibodies to cell surface markers CD4 and CD212, or 
isotype control. Data shown are the means + SEM (n = 3-6). *p<0.05 vs. sedentary EAN 
control; two-way ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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Figure 49. Pre-induction forced-exercise does not affect circulating Th2 cell bias. 
Blood was collected from treated rats near onset (post-induction day 14) or near peak of 
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently 
tagged monoclonal antibodies to cell surface markers CD4 and CD278, or isotype 
control. Data shown are the means + SEM (n = 3-6). These data were analyzed by two-
way ANOVA with post hoc Holm-Sidak multiple comparison test and were found to be 
statistically indistinguishable. 
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Figure 50. Pre-induction forced-exercise does not affect circulating Tc cell bias. 
Blood was collected from treated rats near onset (post-induction day 14) or near peak of 
disease (post-induction day 18) and gated lymphocytes were stained with fluorescently 
tagged monoclonal antibody to cell surface marker CD8 or isotype control. Data shown 
are the means + SEM (n = 3-6). p<0.05 vs. respective post-induction day 14 values; two-
way ANOVA with post hoc Holm-Sidak multiple comparison analysis. 
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CHAPTER V 
DISCUSSION 
Guillain-Barré Syndrome (GBS) is an acute acquired autoimmune mediated 
human peripheral neuropathy with an incidence of about four cases per 100,000 people. 
In North America and Europe, GBS typically presents in the form of acute inflammatory 
demyelinating polyneuropathy (AIDP), where autoreactive pro-inflammatory 
lymphocytes and macrophages invade the myelin, thus demyelinating and damaging the 
axon, leading to paraparesis, paralysis, and areflexia of the limbs. The treatment of 
AIDP/GBS is currently palliative and utilizes non-specific immune-modulating therapies. 
However, these benefits are generally observed only if treatment is administered early in 
the course of the disease (Hughes and Cornblath, 2005; Vucic et al., 2009). A better 
understanding of the autoimmune pathogenesis is crucial for development of better 
treatments for this peripheral neuropathy. 
A major finding of this dissertation is that a three-week regimen of moderate 
forced-exercise attenuates the clinical severity, weight loss, and peripheral nerve damage 
of P2 peptide induced experimental autoimmune neuritis (EAN) in Lewis rats, an animal 
model of GBS. EAN is an inducible autoimmune disease that involves the activation, 
proliferation, and differentiation of the pro-inflammatory autoreactive adaptive immune 
cells in the secondary lymphoid organs. These autoreactive adaptive immune cells then 
egress from the secondary lymphoid organs (e.g. lymph nodes and spleen) to home and 
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demyelinate peripheral nerves leading to weakness and paralysis in the hind limbs. 
Exercise has been shown to have anti-inflammatory effects on innate and adaptive 
immune cells. Our results show for the first time that in forced-exercise EAN rats, there 
is increased retention of adaptive immune cells in the popliteal lymph nodes and spleens. 
Lymphocytes obtained from popliteal lymph nodes of forced-exercise EAN rats have an 
increased capacity to proliferate near peak of disease when stimulated with P2 peptide, 
and a decreased capacity to proliferate near peak of disease when stimulated with 
concanavalin A (ConA). Moreover, the supernatant obtained from the lymphocyte 
proliferation assays of forced-exercise EAN rats near onset and peak of disease show a 
marked increase in the anti-inflammatory cytokine interleukin-10 (IL-10). Splenic 
lymphocytes obtained from spleens of forced-exercise EAN rats have an increase 
capacity to proliferate when stimulated with ConA. Flow cytometric analysis of adaptive 
immune cells obtained from popliteal lymph nodes, spleen, and blood of forced-exercise 
EAN rats showed a clear decrease in pro-inflammatory type 1 helper T (Th1) cells. These 
results illustrate that forced-exercise has anti-inflammatory effects that can attenuate 
EAN in rats. To our knowledge, this is the first study to showed attenuation of the clinical 
severity of EAN by moderate forced-exercise. 
Forced-exercise via treadmill allows for strict control of when, how long, and how 
far the rats run. A voluntary wheel-running paradigm was tried, but the male Lewis rats 
we used ran very little distances. Lewis rats that had access to wheels ran about 2 km per 
24-hour period (data not shown). This was judged an unsatisfactory distance, so a 10% 
food restriction was implemented to increase the running distance of the Lewis rats 
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(Holloszy et al., 1985; Holloszy and Schechtman, 1991; Sherwin, 1998; Duclos et al., 
2005). After food restriction, half the rats ran 8 km per a 24-hour period, while the other 
half of rats ran about 4 km per 24-hour period (data not shown). This phenomenon of 
high-capacity and low-capacity runners is described in the literature, and most likely due 
to individual genetic differences between the rats (Britton and Koch, 2005). Due to the 
extra variability from the food restriction and voluntary wheel-running distances, it was 
decided that treadmill training would be best exercise model. 
However, forced-exercise via treadmill has a negative aspect; rats run against 
their will, which can be stressful. Studies have shown that, acutely, treadmill training can 
increase the glucocorticoid corticosterone, and decrease corticosteroid-binding globulin 
(CBG), the carrier protein for corticosterone (Moraska et al., 2000; Ploughman et al., 
2005; Brown et al., 2007; Ploughman et al., 2007; Ke et al., 2011). However, voluntary 
exercise can also lead to acute rise in corticosterone (Fediuc et al., 2006). In other studies, 
corticosterone and CBG normalize to physiological levels after eight weeks of chronic 
treadmill exercise (Leasure and Jones, 2008). In the present study, levels of 
corticosterone and CBG were not measured during exercise, and were only measured 
near onset and peak of EAN. Near onset and peak of EAN, there were no difference in 
stress hormone between sedentary and forced-exercise groups, or between non-EAN rats, 
but a glucocorticoid difference might have appeared if measurements were taken early in 
the exercise regimen. The levels of corticosterone and CBG in this study were similar to 
non-stressed Lewis rats (Dhabhar et al., 1995; Martin et al., 2000; Duclos et al., 2001). 
EAN is an autoimmune disease mediated by pro-inflammatory autoreactive Th1 
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cells (Constantinescu et al., 1998; Gold et al., 2000; Maurer and Gold, 2002). However, 
EAN is not the only autoimmune disease mediated by Th1 cells (Gold et al., 1997; 
Constantinescu et al., 1998; Elenkov et al., 2000; Gold et al., 2000), and there have been 
studies on how exercise affects these similar autoimmune diseases. For example, the 
effects of forced-exercise were studied in rats with experimental autoimmune 
encephalomyelitis (EAE), an animal model of multiple sclerosis (MS). In these studies 
(Le Page et al., 1994; Le Page et al., 1996), forced-exercise was shown to decrease 
overall clinical severity and delay the onset, but did not decrease peak severity, of EAE in 
rats. However, these studies implemented a different exercise regimen. In these studies, 
the rats underwent acute severe exercise; the rats exercised either two days before or a 
few days after the induction of EAE. In another study (Rossi et al., 2009), mice with EAE 
had access to a voluntary wheel after induction. This acute voluntary exercise attenuated 
the course of EAE. In the present study, a chronic moderate forced-exercise regimen was 
used three weeks before induction of EAN. This pre-induction chronic exercise has been 
shown to have additional beneficial systemic effects, such as decreased inflammation, 
compared to acute exercise (Flynn et al., 2007; Gleeson, 2007; Haaland et al., 2008; 
Campbell et al., 2009; Lira et al., 2009; Rosa Neto et al., 2010; Teixeira-Lemos et al., 
2011b). In our study, chronic pre-induction exercise led to a decrease in clinical severity 
of EAN. Moreover, chronic exercise caused the forced-exercise rats to peak in clinical 
severity 1.3 days earlier than sedentary rats. This could be attributed to exercise 
attenuating the clinical severity of EAN and stunting EAN development. 
In our study, we used two methods of EAN induction in the rat: induction of 
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severe EAN using P2 peptide emulsified in complete Freund’s adjuvant (CFA) injected 
into the left footpad or induction of mild EAN using P2 peptide emulsified in CFA 
injected into the base of the tail. Injection of P2 peptide emulsified in CFA in either the 
footpad or base of the tail causes a local inflammatory response, edema, and tissue 
necrosis. We induced mild EAN in the base of the tail because our preliminary 
experimental design involved rats exercising throughout the course of EAN. Injecting in 
the footpad would have inhibited these rats from running after induction due to the local 
inflammatory response. After these preliminary experiments, we investigated whether 
pre-induction exercise alone could attenuate EAN. Our clinical data show that inducing 
EAN by footpad injection leads to a more severe disease state than inducing in the base 
of the tail. In fact, previous reports about the severity of EAN induced in the base of the 
tail (Zhang et al., 2008b) or in the footpad (Weishaupt et al., 1997; Stienekemeier et al., 
1999; Stienekemeier et al., 2001; Ahn et al., 2010) correspond with our data. In other 
reports, base of the tail injections with twice the amount of antigenic P2 peptide was used 
to obtain clinical scores on par with footpad injections (Moalem-Taylor et al., 2007; 
Lonigro and Devaux, 2009). 
It is known that the dosage of antigen used to induce EAN will change the clinical 
severity of EAN (Hahn et al., 1988). In this study, the same dose of P2 peptide was used 
in the footpad and base of the tail injection. The difference of clinical severity between 
the two injection sites could be explained by a difference in lymphatics at the injection 
site and the injection method. Regarding lymphatics, somatic areas subject to 
environmental hazards, such as the footpads, possess a diffuse regional drainage pattern, 
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while the base of the tail does not share this lymphatics feature. In addition, the footpad 
injections (popliteal lymph nodes) are closer to lymphoid organs than the base of the tail 
injections (gluteal lymph nodes) (Tilney, 1971). Moreover, there were two injection 
methods used: intradermal or subcutaneous injection. The tail involves an intradermal 
injection, which allows the immediate uptake of the injected material by the lymphatics. 
This shortens the time that antigen-presenting cells (APCs) have to process and present 
the antigen, which causes a less robust innate and adaptive immune response, leading to 
an attenuated disease course (Tilney, 1970; Romagnani, 2006; Waldner, 2009; Torres-
Aguilar et al., 2010). In contrast, the footpad involves a subcutaneous injection, which 
allows for a far slower uptake of the injected material by the lymphatics and systemic 
circulation. The popliteal lymph nodes, as a result, receive a steady influx of the injected 
material (Tilney, 1971). The slow uptake of subcutaneous injection allows for ample time 
for the uptake, processing, and presentation of the injected material by APCs, which then 
migrate to the draining lymph to initiate the adaptive immune response (Romagnani, 
2006; Waldner, 2009; Torres-Aguilar et al., 2010). Coupled with the diffuse lymphatics, 
the proximity of popliteal lymph nodes, and the subcutaneous injection, the footpad is 
optimal for an innate and adaptive immune response leading to robust EAN disease. 
In the present study, there was a significant difference in weight gain between 
sedentary and forced-exercised rats. Both groups gained weight during the weeks before 
EAN induction, but the forced-exercise group gained significantly less weight. This has 
been reported in other studies, both in treadmill (Martin et al., 2000; Moraska et al., 2000; 
Leasure and Jones, 2008) and voluntary wheel-running (Fediuc et al., 2006; Droste et al., 
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2007). However, we did not test whether the weight loss was due to changes in metabolic 
adaptations or food intake (Sherwin, 1998). Weight loss is a symptom of EAN, and the 
greater the clinical severity of EAN the greater the weight loss (Rostami et al., 1990; 
Gabriel et al., 1997; Kafri et al., 2005; Lin et al., 2007; Moalem-Taylor et al., 2007; 
Sarkey et al., 2007; Zhang et al., 2008b; Tran et al., 2010). Both forced-exercise and 
sedentary rats with severe EAN lost weight, but the forced-exercise rats loss significantly 
less weight. The attenuated weight loss is consistent with the attenuated clinical severity 
observed in forced-exercise EAN rats. 
Peripheral nerve conduction studies were used to measure the EAN-induced 
changes of compound muscle action potential (CMAP) amplitudes and motor nerve 
conduction velocities (MNCVs) in the sciatic and tibial nerves (Gabriel et al., 1997; 
Taylor and Pollard, 2001, 2003; Lin et al., 2007; Sarkey et al., 2007). CMAP amplitudes 
and MNCV deficits are indicative of axonal damage and demyelination (Hughes and 
Cornblath, 2005; Daube and Rubin, 2009). The clinical severity of EAN is associated 
with deficits of CMAP amplitudes and MNCVs, with the more severe EAN 
corresponding with greater deficits (Taylor and Pollard, 2001, 2003; Lin et al., 2007; 
Sarkey et al., 2007). However, in one study, the clinical severity of EAN was not 
correlated with deficits of CMAP amplitudes and MNCVs; a greater clinical score did not 
lead to greater CMAP amplitudes deficits (Gabriel et al., 1997). These conflicting reports 
could be due to the size and body temperature of the rats, type of stimulating and 
recording electrodes used, and the clinical severity of EAN (Taylor and Pollard, 2001, 
2003; Kurokawa et al., 2004). Small but significant changes in clinical severity of EAN 
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(Gabriel et al., 1997) might be indistinguishable, but large changes can be distinguished 
(Taylor and Pollard, 2001, 2003; Lin et al., 2007; Sarkey et al., 2007), by peripheral 
nerve conduction studies. 
Exercise is also known to protect from CMAP and MNCV deficits in peripheral 
neuropathies (Fisher et al., 2003; Balducci et al., 2006; Fisher et al., 2007). Forced-
exercise protected against CMAP amplitude deficits in rats induced with mild EAN in the 
base of the tail. However, pre-induction forced-exercise did not protect against CMAP 
amplitude deficits in rats induced with severe EAN in the footpad. Exercise also did not 
protect against MNCV deficits in either EAN induction method. The difference in CMAP 
amplitude protection between induction methods could be attributed to the more 
clinically severe EAN in footpad injection than base of the tail. A previous study showed 
that CMAP amplitude deficits were not observed until after the clinical score revealed 
paraparesis or paraplegia in the hind legs (Taylor and Pollard, 2001, 2003). EAN 
induction in the base of the tail leads to a less severe course of disease compared to 
footpad injection, and forced-exercise decreases clinical severity in both injection 
methods. Due to the combined effect of injection method and exercise, forced-exercise 
rats induced in the base of tail never developed paraparesis of the hind legs, a 
manifestation of severe clinical disease that has been associated with CMAP amplitude 
deficits. Even though pre-induction forced-exercise decreased clinical severity of severe 
EAN compared to sedentary rats, both groups developed paraparesis, which were 
revealed in the nerve conduction studies. A lack of change in CMAP amplitudes between 
the forced-exercise and sedentary rats with severe EAN injected in the footpad, and a 
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lack of change in MNCV between the forced-exercise and sedentary rats in both injection 
methods, could be due to the insensitivity of nerve conduction studies to distinguish small 
even if meaningful differences in clinical severity of EAN (Gabriel et al., 1997). 
CMAP amplitudes stimulated from the rat hip (proximal) or ankle (distal), and 
recorded from the plantar muscle demonstrate physiological temporal dispersion, which 
is calculated as an R ratio (proximal to distal ratio, normal ratio > 0.7). A low R ratio 
(abnormal ratio < 0.7) can signify that abnormal temporal dispersion or conduction block 
is occurring, signifying segmental or multifocal demyelination (van der Meche et al., 
1988; Harvey and Pollard, 1992; Lin et al., 2007; Daube and Rubin, 2009; Uncini et al., 
2010). This decrease in R ratio has been described in patients with GBS, suggesting that 
demyelination of peripheral nerves is not uniformly distributed (van der Meche et al., 
1988; Brown and Snow, 1991; Uncini et al., 2010). Specifically, in AIDP, this decrease 
of R ratios has been shown to occur early in the disease when the proximal CMAP 
amplitudes have decreased substantially while distal CMAP amplitudes have decreased 
minimally, while later in the disease both proximal and distal CMAP amplitudes have 
decreased substantially (Uncini et al., 2010). Even though both proximal and distal 
CMAP amplitudes were decreased in forced-exercise and sedentary rats with severe EAN 
there was a decrease of R ratios near peak of disease in forced-exercise EAN rats, but not 
in sedentary EAN rats. This could signify in forced-exercise EAN rats the distal tibial 
nerves were relatively spared in comparison to the proximal sciatic nerves while this was 
not true for sedentary EAN rats. The proximal ends of peripheral nerves are known to be 
more deficient in the blood-nerve barrier compared to other segments of the nerve, and 
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are more susceptible to cellular and humoral infiltrates of the immune system (Jacobs et 
al., 1976; Brown and Snow, 1991). Attenuation of the clinical severity of severe EAN 
due to pre-induction forced-exercise could be explained by an attenuation of the 
immunological injury of the distal tibial nerves. In contrast, there were no differences in 
R ratios between forced-exercise and sedentary rats with mild EAN injected in the base 
of the tail. This is probably due to decreased clinical severity of the base of tail injection. 
Clinical severity of EAN has been correlated with neuropathological changes in 
sciatic nerves, with greater clinical severity corresponding to greater immune cell 
infiltrates, edema, demyelination, and axonal damage (Harvey and Pollard, 1992; 
Gregorian and Rostami, 1994; Spies et al., 1995b; Araga et al., 1999; Pelidou et al., 2000; 
Laura et al., 2006; Castro et al., 2007; Deng and Zhou, 2007; Sarkey et al., 2007; Yun et 
al., 2007; Zhang et al., 2008a; Tan et al., 2009; Zhang et al., 2009a; Zhang et al., 2009d; 
Zhang et al., 2009e; Tran et al., 2010). However, there is a conflicting report of 
attenuation of clinical severity of EAN without changes in neuropathological score. In 
this study, there were significant but small changes in EAN clinical severity (difference 
of about clinical score of 1 to 1.5) (Gabriel et al., 1997). In the studies that reported 
neuropathological score differences, the differences of EAN clinical severity were much 
larger (difference of a clinical score of > 2) (Gregorian and Rostami, 1994; Spies et al., 
1995b; Araga et al., 1999; Pelidou et al., 2000; Laura et al., 2006; Castro et al., 2007; 
Deng and Zhou, 2007; Sarkey et al., 2007; Yun et al., 2007; Zhang et al., 2008a; Tan et 
al., 2009; Zhang et al., 2009a; Zhang et al., 2009d; Zhang et al., 2009e; Tran et al., 2010). 
The difference in attenuation of EAN could explain the discrepancy in neuropathological 
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score. In addition, neuropathological changes are also greater in the sciatic nerve of the 
leg that was injected compared to the sciatic nerve of the un-injected foot (Harvey and 
Pollard, 1992). In our study, we did not observe a difference in neuropathological score 
between forced-exercise and sedentary rats with severe EAN injected in the footpad, 
which correlates with the observed lack of change in CMAP amplitudes and MNCVs. As 
reported elsewhere (Harvey and Pollard, 1992), we did observe a difference in 
neuropathological score between injected (left) and un-injected (right) in sedentary and 
forced-exercise EAN rats, although these difference never reached significance. 
EAN is an autoimmune disorder mediated by the pro-inflammatory autoreactive 
Th1 immune cells of the adaptive immune system (Rostami et al., 1990; Rostami and 
Gregorian, 1991; Takai et al., 1995; Fujioka et al., 2000; Gold et al., 2000; Maurer and 
Gold, 2002; Schmidt et al., 2003). When the P2 peptide and CFA emulsion is injected 
into the rat, the innate immune response is activated. APCs, through activation of toll-like 
receptors (TLRs), phagocytose the emulsion, process and present the P2 peptide in the 
context of major histocompatibility complex class (MHC) II with co-stimulatory signals 
CD80 and CD86, and migrate to secondary lymphoid tissue to activate autoreactive naïve 
T cells, which then proliferate and differentiate into pro-inflammatory autoreactive Th1 
cells (Stenger and Modlin, 2002; Toubi and Shoenfeld, 2004; Deng and Zhou, 2007; 
Israeli et al., 2009; Waldner, 2009; Zhang et al., 2009c). These cells then egress from the 
lymphoid tissue to migrate to and cross the blood-nerve barrier to home in on the P2 
protein on the myelin of the peripheral nerves, clonally expand again, release pro-
inflammatory cytokines, activating macrophages and inducing Schwann cell apoptosis, 
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leading to demyelination and axonal damage (Hartung et al., 1995a, b; Fujioka et al., 
2000). 
Exercise increases circulating APCs (Ho et al., 2001; Chiang et al., 2010; 
Suchanek et al., 2010), decreases TLRs and alters APC function (Woods et al., 1999; 
Flynn and McFarlin, 2006; Gleeson et al., 2006; McFarlin et al., 2006; Lambert et al., 
2008; Timmerman et al., 2008; Simpson et al., 2009; Oliveira and Gleeson, 2010), 
increase (Sugiura et al., 2000; Rogers et al., 2008) or decreases (Moraska et al., 2000; 
Nielsen, 2003; Gleeson et al., 2006; Gleeson, 2007; Rosa Neto et al., 2010) lymphocyte 
proliferation, increases differentiation of anti-inflammatory T cells and anti-inflammatory 
cytokines while decreasing pro-inflammatory T cells and cytokines (Lancaster et al., 
2004; Pastva et al., 2004; Yeh et al., 2006; Flynn et al., 2007; Gleeson, 2007; da Silva 
Krause and de Bittencourt, 2008; Donnikov et al., 2008; Haaland et al., 2008; Yeh et al., 
2008; Hewitt et al., 2009b; Lowder et al., 2010; Rosa Neto et al., 2010), impairs T cell-
mediated induction phase of an in vivo immune response (Harper Smith et al., 2011), and 
promotes lymphocyte egress into peripheral tissues (Chen et al., 2010; Turner et al., 
2010; Adams et al., 2011). 
In this study, we quantified immune cells of two lymphoid organs: the popliteal 
lymph nodes, which are close to, and receive direct lymphatics from, the sight of 
injection; and the spleen, which receives indirect lymphatics through the circulatory 
system (Cesta, 2006; Willard-Mack, 2006; DeFranco et al., 2007). We observed increases 
in lymphocyte number near disease peak and splenic lymphocyte concentration near 
disease onset in forced-exercise EAN rat popliteal lymph nodes and spleens, respectively. 
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An increase in splenic lymphocyte concentration due to exercise has been previously 
reported (Ferry et al., 1992). We did not observe an increase in lymphocyte number or 
splenic lymphocyte concentration in sedentary EAN rat popliteal lymph nodes and 
spleen, respectively, for the same time points. Both sedentary and forced-exercise EAN 
rats developed clinical signs, although the forced-exercise rats had attenuated clinical 
signs of EAN. A probable explanation of the decreased quantity of immune cells in 
lymph nodes and spleens, and thus a more severe clinical severity, of sedentary EAN rats 
is an increased egress of these immune cells from these lymphoid organs into the 
periphery where the cells can home in on peripheral nerve myelin (Fujioka et al., 2000). 
Exercise has been shown to affect egress and the migration process of immune cells 
(Chen et al., 2010; Turner et al., 2010; Adams et al., 2011), and our data might support 
decreased egress of immune cells from lymphoid organs from forced-exercise EAN rats. 
Sphingosine-1-phosphate is a major mediator in immune cell egress, but currently there 
are few reports on the effects exercise on sphingosine-1-phosphate which remain 
equivocal (Schwab and Cyster, 2007; Blachnio-Zabielska et al., 2008; Dube et al., 2011). 
Further research needs to be conducted to clarify the increased retention of immune cells 
in forced-exercise animals. 
We normalized (2.0 × 10
6 
cells/ml) and quantified the in vitro stimulated 
proliferative capacity and cytokine secretion of nodal and splenic lymphocytes from the 
popliteal lymph nodes and spleens, respectively, of rats with severe EAN. Proliferation 
assays serve to assess the functional capacity of immune cells (Nielsen, 2003). We also 
stained specific cell surface markers for lymphocytes from lymph nodes, spleens, and 
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blood, and performed flow cytometry to quantify T cell subsets involved in severe EAN 
(Hartung et al., 1995a, b) and altered in exercise (Lancaster et al., 2004; Flynn et al., 
2007; Gleeson, 2007; da Silva Krause and de Bittencourt, 2008; Donnikov et al., 2008; 
Haaland et al., 2008; Lowder et al., 2010; Rosa Neto et al., 2010). Specifically, we 
looked at helper T (Th) cells, which are CD4
+
 (Zhu and Paul, 2008), and cytotoxic T (Tc) 
cells, which are CD8
+
 (Andersen et al., 2006). From the Th cells, we further divided this 
group into pro-inflammatory Th1 cells, which are CD212
+
 (Yamane et al., 2000; Ozenci 
et al., 2001; McQuaid et al., 2003; Kano et al., 2008), and anti-inflammatory Th2 cells, 
which are CD278
+
 (Rojo et al., 2008; Zhu and Paul, 2008; Simpson et al., 2010). We 
further divided Tc cells into activated Tc cells, which are CD212
+
 (McQuaid et al., 2003; 
Bontkes et al., 2005). 
Consistent with previous reports (Rostami and Gregorian, 1991; Yun et al., 2007), 
nodal and splenic lymphocytes from sedentary CFA control rats did not proliferate to P2 
peptide and there were a small amount of pro-inflammatory Th1 cells in the lymph nodes, 
spleen, and blood. 
Sedentary EAN rats near onset of disease had increases in P2 peptide-stimulated 
lymphocyte proliferation and in pro-inflammatory Th1 cytokine IFN-γ (Yun et al., 2007; 
Zhu and Paul, 2008; Bennett and Stuve, 2009). This proliferation data is expected since 
EAN sedentary rats have pro-inflammatory autoreactive Th1 cells primed to P2 peptide 
and will proliferate when stimulated with the antigen (Hughes et al., 1981; Rostami et al., 
1990; Rostami and Gregorian, 1991; Yun et al., 2007). We also showed that this 
increased proliferative capacity returns to baseline with a concomitant decrease of IFN-γ 
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near peak of disease in sedentary EAN rats. Through flow cytometry, we showed an 
increase in Th1 cells in lymph nodes near onset of disease consistent with EAN as Th1-
mediated autoimmune disease (Takai et al., 1995; Fujioka et al., 2000; Gold et al., 2000; 
Maurer and Gold, 2002; Schmidt et al., 2003), and that Th1 cells return to normal levels 
near peak of disease. Near peak of disease, most effector T cells will undergo apoptosis 
or regulatory T cell-induced anergy, and lymphocytes will not proliferate or secrete 
cytokines when stimulated with P2 peptide antigen (Veldman et al., 2006; DeFranco et 
al., 2007; Vignali et al., 2008).  
There have been reports of blunted proliferation (Moraska et al., 2000) or 
increased proliferation (Sugiura et al., 2000; Rogers et al., 2008) of immune cells, and 
increased differentiation of anti-inflammatory T cells and secretion of anti-inflammatory 
cytokines while decreasing pro-inflammatory T cells and cytokines (Jankord and 
Jemiolo, 2004; Lancaster et al., 2004; Goldhammer et al., 2005; Flynn et al., 2007; 
Gleeson, 2007; da Silva Krause and de Bittencourt, 2008; Donnikov et al., 2008; Haaland 
et al., 2008; Rosa Neto et al., 2010) due exercise training. However, there have been no 
reports on effects of exercise and autoimmune disease on immune cell proliferation. 
Forced-exercise slightly blunted the capacity of lymphocytes to proliferate to P2 peptide 
antigen and with a concomitant increase in IL-10 and IFN-γ and a decrease in IL-2 near 
onset of severe EAN. In contrast, we observed sustained P2 peptide-stimulated 
lymphocyte proliferation near peak of disease in forced-exercise EAN rats with only a 
concomitant increase in IFN-γ and IL-2. We also observed in forced-exercise rats 
decreased differentiation of Th1 cells near disease onset in lymph nodes, and that Th1 
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cells levels returned to normal near peak of disease. 
We observed no differences near onset or peak of disease of Th (Takai et al., 
1995; Yun et al., 2007), Tc (Takai et al., 1995), and activated Tc cells in lymph nodes 
among the forced-exercised and sedentary EAN rats. We observed a modest increase near 
peak of disease in Th2 cells in forced-exercise rats. 
Exercise, by releasing IL-6 from contracting muscles, has the capacity to increase 
dendritic cells (DCs) in circulation and to decrease TLRs on APCs, therefore imposing an 
anti-inflammatory immature or semi-mature activation status on the innate immune 
system (Figure 51) (Ho et al., 2001; Flynn and McFarlin, 2006; Gleeson et al., 2006; 
McFarlin et al., 2006; Belkaid and Oldenhove, 2008; Lambert et al., 2008; Nielsen and 
Pedersen, 2008; Timmerman et al., 2008; Simpson et al., 2009; Chiang et al., 2010; Frick 
et al., 2010; Oliveira and Gleeson, 2010; Suchanek et al., 2010). This change in status of 
activation of APCs, which activate naïve Th cells, induces a subset of Th1 cells to secrete 
both the pro-inflammatory cytokine IFN-γ and the anti-inflammatory cytokine IL-10 
(Trinchieri, 2001; Belkaid and Oldenhove, 2008). This unusual secretion of IL-10 is 
thought to occur by recently activated Th1 cells. However, IL-10 secretion is transient, 
and Th1 cells will then only secrete IFN-γ. This could be a regulatory mechanism to keep 
in check the pro-inflammatory immune response (Belkaid and Oldenhove, 2008), thus 
attenuating the clinical severity of EAN. Within the scope of our immune data, when 
stimulated with P2 peptide, lymphocytes from forced-exercise rats obtained near onset 
secrete both IL-10 and IFN-γ, and these lymphocytes obtained from popliteal lymph 
nodes are differentiated into Th1 cells. These Th1 cells limit their own proliferation and 
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differentiation by secreting the anti-inflammatory cytokine IL-10 (Zhu and Paul, 2008). 
Near peak of disease (Figure 52), these Th1 cells lose their ability to secrete the large 
amounts of IL-10 observed near disease onset. These Th1 cells continue to secrete IFN-γ 
leading to proliferation of lymphocytes. This transient secretion of IL-10 near onset of 
disease could account for the decreased amount of Th1, and the slight increase in Th2, 
cells in the lymph nodes. 
Another possibility is that near onset of disease, there is an increase of both Th1 
cells and IL-10-producing type 1 T regulatory 1 (Tr1) cells, and these cells account for 
the increase in IFN-γ and IL-10, respectively (Figure 51). Tr1 cells are crucial in 
regulating pro-inflammatory immune response in autoimmune diseases (Fehervari and 
Sakaguchi, 2004; Veldman et al., 2006). Tr1 cells are differentiated and activated by 
immature DCs, and Tr1 cells blunt the proliferation of Th1 cells by secreting the anti-
inflammatory cytokine IL-10 (Fehervari and Sakaguchi, 2004; Veldman et al., 2006; 
Belkaid and Oldenhove, 2008). In fact, previous reports have shown a small quantity of 
regulatory T cells in EAN rats (Yun et al., 2007; Zhang et al., 2009b). Moreover, it has 
been shown that there are decreased percentages of circulating anti-inflammatory 
regulatory T cells in GBS patients insinuating dysregulation of pro-inflammatory T cells 
(Pritchard et al., 2007; Vucic et al., 2009). Exercise has been shown to increase immature 
DCs (Suchanek et al., 2010) which are implicated in inducing regulatory T cells 
(Fehervari and Sakaguchi, 2004; Veldman et al., 2006; Frick et al., 2010). Exercise has 
been shown to increase regulatory T cells (Lowder et al., 2010). It could be possible that 
after onset of disease the Tr1 cells have migrated into circulation and into the peripheral 
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nerves (Figure 52) (Gillen et al., 1998; Iellem et al., 2001), thus attenuating the clinical 
severity of the disease. When near peak of disease, Th1 lymphocytes no longer have 
regulation by Tr1 cells, thus Th1 cells continue to proliferate and release IFN-γ. Tr1 cell 
secretion of IL-10 near onset of disease could account for the decreased amount of Th1, 
and the slight increase in Th2, cells in the lymph nodes. 
Both of these explanations also account for the decreased secretion of IL-2 in pre-
induction forced-exercised. IL-10 producing Th1 or Tr1 cells induced from immature or 
semi-mature DCs decrease the pro-inflammatory Th1 cell response, and thus decrease IL-
2 in our proliferation assays (Fehervari and Sakaguchi, 2004; Veldman et al., 2006; Zhu 
and Paul, 2008; Frick et al., 2010). An increase in IL-2 seen near disease peak can be due 
to a decrease in IL-10 production from Th1 cells, or the egress of IL-10-producing Tr1 
cells from secondary lymphoid organs. 
We also showed increased levels of TNF-α from severe EAN lymphocytes 
compared to non-EAN lymphocytes, but were no differences compared to forced-
exercise and sedentary EAN lymphocytes. The most likely contributor of TNF-α are 
proliferating macrophages (Elenkov and Chrousos, 2002) or Tc cells (Johnson et al., 
2010). Macrophages and Tc cells contribute to EAN pathogenesis (Constantinescu et al., 
1998; Pelidou et al., 2000; Hughes and Cornblath, 2005; Yun et al., 2007). 
Concerning splenic lymphocyte proliferation, we saw no increase in the capacity 
of immune cells to proliferate when stimulated with P2 peptide in EAN rats. Lymph 
nodes contain resident dendritic cells (DCs), APCs that are dedicated to presenting 
antigen to T cells. The resident DCs are naive until they encounter the immunogenic P2 
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peptide antigen, and these DCs contribute to stimulated lymphocyte proliferation. The 
spleen does not contain naïve DCs, but instead contains macrophages that are intended to 
encounter antigen from the blood and activated DCs that migrated to the spleen. 
Macrophages are APCs, but are not as efficient as DCs at processing and presenting the 
antigen to T cells (DeFranco et al., 2007). In some reports, there were increases in P2 
peptide-stimulated splenic lymphocyte proliferation because irradiated thymocytes were 
used as APCs to activate the adaptive immune cells (Rostami et al., 1990; Rostami and 
Gregorian, 1991). Thymus has a large population of DCs used for positive and negative 
selection of autoreactive T cells (DeFranco et al., 2007), so irradiated thymocytes would 
contain naïve DCs. We believe that the macrophages in our splenic lymphocyte 
proliferation assays were incapable of efficiently presenting the P2 peptide to the T cells, 
and that we might have had increases in proliferation if we had used irradiated 
thymocytes. We would also note that although we did not see P2 peptide-stimulated 
splenic lymphocyte proliferation, we did observe P2 peptide-stimulated splenic 
lymphocyte production of TNF-α in the forced-exercise rats. This P2 peptide-stimulated 
exercise-induced production of TNF-α is probably secreted by CD8+ T cells that have 
migrated to the spleen (Sipos et al., 2008). TNF-α is also produced by macrophages since 
exercise is known to increase macrophage function (Elenkov and Chrousos, 2002; Chen 
et al., 2010). 
Nodal and splenic lymphocytes were also stimulated with ConA, a plant lectin 
that increases T cell subset proliferation through activation of macrophages and immature 
dendritic cells through signaling of TLRs (Rostami et al., 1990; Rostami and Gregorian, 
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1991; Stenger and Modlin, 2002; Toubi and Shoenfeld, 2004; MacLeod and Wetzler, 
2007; Yun et al., 2007; Unitt and Hornigold, 2011). Our data show no difference between 
forced-exercise and sedentary EAN rats in ConA lymphocyte proliferation near onset, 
even though there were more Th1 cells in sedentary EAN lymph nodes. In contrast, our 
data show an increase in ConA lymphocyte proliferation in sedentary EAN rats near peak 
of disease, even though there were equal levels of Th1 cells between sedentary and 
forced-exercise EAN rats. The decreased lymphocyte proliferation in forced-exercised 
EAN rats correlates with an observed increase in the anti-inflammatory cytokine IL-10. 
Activation of TLRs on APCs, depending on the activation status of APCs, is known to 
differentiate and activate naïve T cells to either a pro-inflammatory or an anti-
inflammatory immune state (Kapsenberg, 2003; MacLeod and Wetzler, 2007). For 
example, exercise, by releasing heat shock proteins into the blood, decreases expression 
of TLR1, 2, and 4 on APCs (Flynn and McFarlin, 2006), and this increases the anti-
inflammatory effects of immature DCs that leads to an anti-inflammatory immune state 
(IL-10 production) (Ozdemir et al., 2009). Hence, we see in our results decreased 
proliferation with corresponding production of IL-10 in forced-exercise EAN 
lymphocytes. However, we saw a decrease in proliferation in sedentary EAN 
lymphocytes near onset. A simple explanation of these data is that there are decreased 
amounts of immature DCs in the lymph nodes in which to react to ConA and to activate 
naïve T cells; mature DCs, in contrast, do not react to ConA due to a decrease in TLR 
signaling (MacLeod and Wetzler, 2007). Near peak of disease, immature DCs could 
reappear due to clearance of the P2 peptide, and when stimulated with ConA, DCs can 
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cause robust proliferation of lymphocytes. 
In regards to the splenic lymphocytes, we observed an increase in ConA-
stimulated proliferation and decreased quantity of Th1 cells in forced-exercise rats near 
onset and peak. Sedentary EAN rats have an increased quantity of Th1 cells. The spleen 
contains resident macrophages, and not naïve DCs, and ConA is a potent activator of 
macrophages and naïve DCs through TLRs (Toubi and Shoenfeld, 2004; DeFranco et al., 
2007; MacLeod and Wetzler, 2007). Moreover, naïve T cells are unresponsive to TLR 
ligands, and TLRs are only up-regulated with T cell receptor activation (MacLeod and 
Wetzler, 2007). Since sedentary EAN rats have more Th1 differentiation, it is feasible that 
macrophages have activated by T cells through the T cell receptor, and macrophages have 
egressed from the spleen and are not available to proliferate to ConA or to activate naïve 
T cells. In fact, exercise is known to suppress macrophage migration, and increase 
macrophage function and secretion of IL-6 and TNF-α (Sugiura et al., 2000; Chen et al., 
2010; Teixeira-Lemos et al., 2011a), as has been observed in our experiments. The 
increased proliferation observed in forced-exercise EAN splenic lymphocytes could be 
attributed to an increase in basal levels of macrophages in the spleen, but also to 
increased capacity of the macrophages to proliferate and activate T cells. The increase in 
TNF-α and IL-6 in ConA-stimulated splenic lymphocytes from forced-exercise EAN rats 
could be due to production of TNF-α by macrophages or CD8+ cells (Elenkov and 
Chrousos, 2002; Sipos et al., 2008; Chen et al., 2010), and IL-6 by macrophages (Figure 
53) (Teixeira-Lemos et al., 2011a). 
We observed no differences near onset or peak of disease of Th (Takai et al., 
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1995), Tc (Takai et al., 1995), and Th2 cells in the spleen among the forced-exercised and 
sedentary EAN rats. We did, however, observed near onset an increase in activated Tc 
cells in the spleen in sedentary EAN rats. In patients with MS, and in animal models of 
MS, there is an increase in these effector CD8
+
 cells (Johnson et al., 2010), and an 
increase in activated Tc cells is correlated with an increase in Th1 cells (Joshi and Kaech, 
2008). As observed in our study, the increase of Th1 cells corresponds with an increase in 
activated Tc cells. 
Differentiated T cells in the lymph nodes and spleen must egress to the blood to 
home in on nerves (Hartung et al., 1995a, b; Fujioka et al., 2000). Exercise has been 
shown to increase egress of lymphocytes from the blood into peripheral tissues (Chen et 
al., 2010; Turner et al., 2010; Adams et al., 2011). We observed no differences near onset 
or peak of disease of Th (Takai et al., 1995), Tc (Takai et al., 1995) and Th2 cells in the 
blood among the forced-exercised and sedentary EAN rats. We observed near onset and 
peak an increase in Th1 cells in the blood in sedentary EAN rats, similar to what we 
observed in the lymph nodes and spleen. 
A weakness of this study is that innate immune cell quantity, type, TLR surface 
expression, and function were not measured. In our study, we used molecular mimicry to 
activate the innate immune response against the P2 peptide antigen, which then activated 
the adaptive immune system (Romagnani, 2006; Waldner, 2009; Torres-Aguilar et al., 
2010). The innate immune system is crucial for the development of EAN. The innate 
immune system also undergoes changes to exercise (Ho et al., 2001; Flynn and McFarlin, 
2006; Gleeson et al., 2006; McFarlin et al., 2006; Lambert et al., 2008; Timmerman et al., 
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2008; Simpson et al., 2009; Chiang et al., 2010; Oliveira and Gleeson, 2010; Suchanek et 
al., 2010), which can lead to anti-inflammatory state of the adaptive immune system 
(Lancaster et al., 2004; Flynn et al., 2007; Gleeson, 2007; da Silva Krause and de 
Bittencourt, 2008; Donnikov et al., 2008; Haaland et al., 2008; Rosa Neto et al., 2010). 
The attenuation of EAN in forced-exercised rats is due to immunological changes 
occurring in these rats, but only the adaptive arm of the immune response was studied. 
The hypothesis that the anti-inflammatory effect of exercise is due to decreased TLR 
signaling on APCs that leads to secretion of IL-10 by either Th1 or Tr1 cells at the onset 
of disease needs to be further studied. 
In summary, we show an attenuation of the clinical severity of EAN by forced-
exercise. Lymphocytes obtained from popliteal lymph nodes of forced-exercise EAN rats 
are in an anti-inflammatory immune state demonstrated by their secretion of the anti-
inflammatory cytokine IL-10. Flow cytometric analysis of adaptive immune cells 
obtained from popliteal lymph nodes, spleens, and blood of forced-exercise EAN rats 
showed a clear decrease in pro-inflammatory Th1 cells. These results illustrate that 
forced-exercise has anti-inflammatory effects that can attenuate EAN in rats.  
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Figure 51. Pre-induction forced-exercise attenuates severe EAN by decreasing nodal 
Th1 differentiation, and secretion of IL-2, while increasing IL-10 near disease onset. 
At onset of experimental autoimmune neuritis (EAN), mature dendritic cells (mDCs) 
have high expression of MHCII, CD80, and CD86, which leads to robust proliferation 
and differentiation of type 1 helper T (Th1) cells and secretion of interferon-γ (IFN-γ) 
and interleukin-2 (IL-2). Exercise, by decreasing toll-like receptors (TLRs), and 
increasing circulating interleukin-6 (IL-6), increases immature (iDCs) and semi-mature 
(smDCs) dendritic cells that induce transient interleukin-10 (tIL-10)-producing Th1 cells, 
and/or IL-10-producing type 1 regulatory T (Tr1) cells, which causes decreased 
differentiation of Th1 cells and secretion of IL-2, while secreting of IFN-γ and IL-10.  
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Figure 52. Pre-induction forced-exercise alters severe EAN-production of nodal 
lymphocyte IFN-γ near disease peak. Near peak of experimental autoimmune neuritis 
(EAN), type 1 helper T (Th1) cells are undergoing apoptosis or anergy, thus decreasing 
immune cells proliferation and interferon-γ (IFN-γ) secretion. Exercise, by decreasing 
toll-like receptors (TLRs), and increasing interleukin-6 (IL-6), induced transient 
interleukin-10 (tIL-10)-producing Th1 cells. At peak, these tIL-10 Th1 cells become Th1 
cells that no longer secrete IL-10, but only secrete IFN-γ and interleukin-2 (IL-2), which 
increases immune cell proliferation. Another possibility is that IL-10-producing type 1 
regulatory T cells have egressed from the lymph nodes, thus disinhibiting Th1 cells that 
secrete IFN-γ and interleukin-2 (IL-2), which increases immune cell proliferation 
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 Figure 53. Pre-induction forced-exercise alters severe EAN-induced splenic 
lymphocyte proliferation and cytokine secretion near disease onset and peak. Near 
onset or peak of experimental autoimmune neuritis (EAN), type 1 helper T (Th1) cells 
activate macrophages. Exercise decreases macrophage migration from the spleen, and 
increases cytokine secretions of IL-6 and TNF-α, which leads to further activation of T 
cells and proliferation near disease onset and peak.  
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